PRA (PRAA) 10-Q 6 Nov 23 2023 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2023	Oct. 31, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	000-50058
Entity Registrant Name	PRA Group, Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-3078675
Entity Address, Address Line One	120 Corporate Boulevard
Entity Address, City or Town	Norfolk
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	23502
City Area Code	888
Local Phone Number	772-7326
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	PRAA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		39,244,145
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001185348

Recently Issued Accounting Stan

Recently Issued Accounting Standards	9 Months Ended
	Sep. 30, 2023
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recently Issued Accounting Standards	Recently Issued Accounting Standards: Recently issued accounting standards not yet adopted: The Company does not expect that any recently issued accounting pronouncements will have a material effect on its Consolidated Financial Statements.

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Assets [Abstract]
Cash and Cash Equivalents, at Carrying Value	$ 105,172	$ 83,376
Investments	74,729	79,948
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net	3,460,804	3,295,008
Income Taxes Receivable, Current	38,695	31,774
Deferred Income Tax Assets, Net	55,493	56,908
Operating Lease, Right-of-Use Asset	47,156	54,506
Property, Plant and Equipment, Net	38,562	51,645
Goodwill	412,513	435,921
Other Assets	96,851	86,588
Assets, Total	4,329,975	4,175,674
Liabilities [Abstract]
Accounts Payable	6,159	7,329
Accrued Liabilities	106,391	111,395
Accrued Income Taxes	15,946	25,693
Deferred Tax Liabilities, Net, After Adjustments	14,185	42,918
Interest-Bearing Deposit Liabilities	100,505	112,992
Debt, Long-Term and Short-Term, Combined Amount	2,832,225	2,494,858
Operating Lease, Liability	51,658	59,384
Other Liabilities, Current	12,919	34,355
Liabilities, Total	$ 3,139,988	$ 2,888,924
Preferred Stock, Shares Outstanding	0	0
Preferred stock, shares issued	0	0
Preferred Stock, Shares Authorized	2,000,000	2,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares, Outstanding	39,243,000	38,980,000
Common stock, shares issued	39,243,000	38,980,000
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Equity, Attributable to Parent [Abstract]
Preferred Stock, Value, Issued	$ 0	$ 0
Common Stock, Value, Outstanding	392	390
Additional Paid in Capital, Common Stock	4,157	2,172
Retained Earnings (Accumulated Deficit)	1,498,330	1,573,025
Accumulated Other Comprehensive Income (Loss), Net of Tax	(387,289)	(347,926)
Equity, Attributable to Parent, Total	1,115,590	1,227,661
Equity, Attributable to Noncontrolling Interest	74,397	59,089
Equity, Including Portion Attributable to Noncontrolling Interest, Total	1,189,987	1,286,750
Liabilities and Equity, Total	$ 4,329,975	$ 4,175,674

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	39,243,000	38,980,000
Common stock, shares outstanding	39,243,000	38,980,000

Consolidated Income Statements

Consolidated Income Statements - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues:
Financing Receivable, Allowance For Credit Losses, Recoveries Reclassified To Income	$ 189,960	$ 185,853	$ 562,492	$ 587,394
Financing Receivable, Allowance For Credit Loss, Changes In Estimated Recoveries	22,156	48,336	6,380	134,817
Financing Receivable, Allowance For Credit Loss, Portfolio Revenue	212,116	234,189	568,872	722,211
Revenue From Contract With Customer And Fee Revenue, Excluding Assessed Tax	4,314	10,618	12,264	21,463
Revenues, Total	216,430	244,807	581,136	743,674
Operating Expenses [Abstract]
Labor and Related Expense	69,517	70,382	217,708	215,615
Legal Fees	9,839	8,963	28,228	29,390
Legal Costs	20,761	23,391	66,228	57,694
Agency Fees	19,436	15,160	54,491	47,374
Outside Fees And Services Expenses	18,858	24,618	62,064	71,489
Communication	9,881	9,951	30,525	32,062
Rent And Occupancy	4,426	4,669	13,193	14,289
Depreciation, Depletion and Amortization, Nonproduction	3,273	3,741	10,344	11,384
Impairment, Long-Lived Asset, Held-for-Use	5,037	0	5,037	0
Other Cost and Expense, Operating	12,356	13,144	38,355	37,885
Operating Expenses, Total	173,384	174,019	526,173	517,182
Operating Income (Loss), Total	43,046	70,788	54,963	226,492
Nonoperating Income (Expense) [Abstract]
Interest Income (Expense), Net	(49,473)	(32,455)	(130,778)	(95,765)
Gain (Loss), Foreign Currency Transaction, before Tax	564	4	984	791
Other Nonoperating Income (Expense)	(500)	(83)	(1,380)	(754)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	(6,363)	38,254	(76,211)	130,764
Income Tax Expense (Benefit)	1,788	11,072	(15,317)	29,828
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total	(8,151)	27,182	(60,894)	100,936
Net Income (Loss) Attributable to Noncontrolling Interest	4,111	2,450	13,801	(252)
Net Income (Loss) Attributable to Parent, Total	$ (12,262)	$ 24,732	$ (74,695)	$ 101,188
Earnings Per Share [Abstract]
Basic (in dollars per share)	$ (0.31)	$ 0.63	$ (1.91)	$ 2.54
Diluted (in dollars per share)	$ (0.31)	$ 0.63	$ (1.91)	$ 2.52
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic (shares)	39,242	39,018	39,155	39,858
Diluted (shares)	39,242	39,170	39,155	40,125

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ (8,151)	$ 27,182	$ (60,894)	$ 100,936
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax	(34,279)	(91,390)	(28,746)	(194,656)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(7,660)	19,590	(6,772)	44,007
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax	(26)	133	22	(269)
Other Comprehensive Income (Loss), Net of Tax, Total	(41,965)	(71,667)	(35,496)	(150,918)
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total	(50,116)	(44,485)	(96,390)	(49,982)
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest	1,436	9,049	17,668	8,008
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total	$ (51,552)	$ (53,534)	$ (114,058)	$ (57,990)

Consolidated Statement of Chang

Consolidated Statement of Changes in Equity - USD ($) $ in Thousands	Total	UNITED STATES	UNITED KINGDOM	BRAZIL	Outside the United States	Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive (Loss)	Accumulated Other Comprehensive (Loss) Cumulative Effect, Period of Adoption, Adjusted Balance	Noncontrolling Interest	Noncontrolling Interest Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2021							41,008,000
Beginning balance at Dec. 31, 2021	$ 1,324,837						$ 410		$ 0		$ 1,552,845		$ (266,909)		$ 38,491
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	34,618										39,972				(5,354)
Currency translation adjustments	12,270												4,780		7,490
Cash flow hedges	18,580												18,580
Debt securities available-for-sale	(160)												(160)
Repurchase and cancellation of common stock (shares)							860,000
Repurchase and cancellation of common stock	(39,454)						$ (9)		4,527		(43,972)
Vesting of restricted stock (in shares)							262,000
Vesting of restricted stock	0						$ 3		(3)
Share-based compensation expense	3,891								3,891
Employee stock relinquished for payment of taxes	(8,415)								(8,415)
Ending balance (in shares) at Mar. 31, 2022							40,410,000
Ending balance at Mar. 31, 2022	1,346,167						$ 404		0		1,548,845		(243,709)		40,627
Beginning balance (in shares) at Dec. 31, 2021							41,008,000
Beginning balance at Dec. 31, 2021	1,324,837						$ 410		0		1,552,845		(266,909)		38,491
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash flow hedges	44,007
Debt securities available-for-sale	(269)
Ending balance (in shares) at Sep. 30, 2022							38,976,000
Ending balance at Sep. 30, 2022	1,182,589						$ 389		0		1,557,066		(426,086)		51,220
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Changes in estimated recoveries	134,817
Revenues	743,674	$ 426,675	$ 126,866	$ 22,629	$ 167,504
Beginning balance (in shares) at Mar. 31, 2022							40,410,000
Beginning balance at Mar. 31, 2022	1,346,167						$ 404		0		1,548,845		(243,709)		40,627
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	39,136										36,484				2,652
Currency translation adjustments	(115,536)												(109,707)		(5,829)
Cash flow hedges	5,837												5,837
Debt securities available-for-sale	(242)												(242)
Repurchase and cancellation of common stock (shares)							808,000
Repurchase and cancellation of common stock	(34,935)						$ (8)		(3,835)		(31,092)
Vesting of restricted stock (in shares)							37,000
Share-based compensation expense	3,849								3,849
Employee stock relinquished for payment of taxes	(14)								(14)
Ending balance (in shares) at Jun. 30, 2022							39,639,000
Ending balance at Jun. 30, 2022	1,242,367						$ 396		0		1,554,237		(347,821)		35,555
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Distributions to noncontrolling interest	(3,494)														(3,494)
Noncontrolling Interest, Increase From Contributions	1,599														1,599
Net income	27,182										24,732				2,450
Currency translation adjustments	(91,390)												(97,988)		6,598
Cash flow hedges	19,590												19,590
Debt securities available-for-sale	133												133
Repurchase and cancellation of common stock (shares)							663,000
Repurchase and cancellation of common stock	(25,001)						$ (7)		(3,091)		(21,903)
Share-based compensation expense	3,101								3,101
Employee stock relinquished for payment of taxes	(10)								(10)
Ending balance (in shares) at Sep. 30, 2022							38,976,000
Ending balance at Sep. 30, 2022	1,182,589						$ 389		0		1,557,066		(426,086)		51,220
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Changes in estimated recoveries	48,336
Distributions to noncontrolling interest	(1,127)														(1,127)
Noncontrolling Interest, Increase From Contributions	7,744														7,744
Revenues	244,807	138,398	37,032	14,293	55,084
Long-Lived Assets	$ 104,709	80,496	10,762	3	13,448
Beginning balance (in shares) at Dec. 31, 2022	38,980,000							38,980,000
Beginning balance at Dec. 31, 2022	$ 1,286,750					$ 1,286,750		$ 390		$ 2,172		$ 1,573,025	(347,926)	$ (347,926)		$ 59,089
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	(53,903)										(58,629)				4,726
Currency translation adjustments	(1,550)												(4,101)		2,551
Cash flow hedges	(4,831)												(4,831)
Debt securities available-for-sale	128												128
Vesting of restricted stock (in shares)							190,000
Vesting of restricted stock	0						$ 2		(2)
Share-based compensation expense	3,799								3,799
Employee stock relinquished for payment of taxes	$ (5,684)								(5,684)
Ending balance (in shares) at Mar. 31, 2023								39,170,000
Ending balance at Mar. 31, 2023						1,224,709		$ 392		285		1,514,396		(356,730)		66,366
Beginning balance (in shares) at Dec. 31, 2022	38,980,000							38,980,000
Beginning balance at Dec. 31, 2022	$ 1,286,750					1,286,750		$ 390		2,172		1,573,025	(347,926)	(347,926)		59,089
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash flow hedges	(6,772)
Debt securities available-for-sale	$ 22
Ending balance (in shares) at Sep. 30, 2023	39,243,000							39,243,000
Ending balance at Sep. 30, 2023	$ 1,189,987					1,189,987		$ 392		4,157		1,498,330	(387,289)	(387,289)		74,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Changes in estimated recoveries	6,380
Revenues	581,136	258,848	99,547	69,383	153,358
Beginning balance (in shares) at Mar. 31, 2023								39,170,000
Beginning balance at Mar. 31, 2023						1,224,709		$ 392		285		1,514,396		(356,730)		66,366
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,160										(3,804)				4,964
Currency translation adjustments	7,083												3,091		3,992
Cash flow hedges	5,719												5,719
Debt securities available-for-sale	(80)												(80)
Vesting of restricted stock (in shares)							72,000
Share-based compensation expense	2,715								2,715
Employee stock relinquished for payment of taxes	(459)								(459)
Ending balance (in shares) at Jun. 30, 2023								39,242,000
Ending balance at Jun. 30, 2023						1,239,674		$ 392		2,541		1,510,592	(348,000)	(348,000)		74,149
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Distributions to noncontrolling interest	(1,173)														(1,173)
Net income	(8,151)										$ (12,262)				4,111
Currency translation adjustments	(34,279)												(31,603)		(2,676)
Cash flow hedges	(7,660)												(7,660)
Debt securities available-for-sale	(26)												(26)
Vesting of restricted stock (in shares)							1,000
Share-based compensation expense	1,629								1,629
Employee stock relinquished for payment of taxes	$ (13)								$ (13)
Ending balance (in shares) at Sep. 30, 2023	39,243,000							39,243,000
Ending balance at Sep. 30, 2023	$ 1,189,987					$ 1,189,987		$ 392		$ 4,157		$ 1,498,330	$ (387,289)	$ (387,289)		$ 74,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Changes in estimated recoveries	22,156
Distributions to noncontrolling interest	(1,187)														$ (1,187)
Revenues	216,430	105,456	30,978	24,749	55,247
Long-Lived Assets	$ 85,718	$ 61,788	$ 11,233	$ 3	$ 12,694

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net income	$ (60,894)	$ 100,936
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Share-Based Payment Arrangement, Noncash Expense	8,143	10,841
Depreciation, amortization and impairment	15,381	11,384
Gain (Loss) on Extinguishment of Debt	(343)	0
Amortization of Debt Issuance Costs and Discounts	7,045	7,653
Financing Receivable, Allowance For Credit Loss, Changes In Estimated Recoveries	(6,380)	(134,817)
Deferred Income Taxes and Tax Credits	(26,276)	8,710
Realized Gain (Loss), Foreign Currency Transaction, before Tax	(31,783)	21,356
Equity Securities, FV-NI, Realized Gain (Loss)	1,094	(175)
Other Noncash Income (Expense)	(1,318)	159
Increase (Decrease) in Operating Capital [Abstract]
Increase (Decrease) in Other Operating Assets	1,111	(2,547)
Increase (Decrease) in Accounts Payable	(1,123)	3,028
Increase (Decrease) in Income Taxes	(18,259)	(155)
Increase (Decrease) in Other Accrued Liabilities	(4,685)	(7,655)
Increase (Decrease) in Other Operating Liabilities	385	(22,521)
Increase (Decrease) In Operating Lease Asset (Liability)	(370)	389
Net Cash Provided by (Used in) Operating Activities, Total	(118,272)	(3,414)
Net Cash Provided by (Used in) Investing Activities [Abstract]
Payments to Acquire Property, Plant, and Equipment	(2,306)	(10,698)
Payments to Acquire Finance Receivables	(875,373)	(561,901)
Proceeds From Recovery Of Negative Financing Receivable Allowance	695,386	765,732
Payments For (Proceeds From) Marketable Securities)	(60,058)	(2,292)
Proceeds from Sale and Maturity of Marketable Securities	62,762	4,565
Net Cash Provided by (Used in) Investing Activities, Total	(179,589)	195,406
Net Cash Provided by (Used in) Financing Activities [Abstract]
Proceeds from Long-Term Lines of Credit	695,651	1,343,434
Repayments of Long-Term Lines of Credit	(389,658)	(1,389,371)
Repayments of Convertible Debt	345,000	0
Proceeds from Issuance of Other Long-Term Debt	400,000	0
Repayments of Other Long-Term Debt	(7,500)	(7,500)
Payments On Senior Notes	(3,657)	0
Payments for Repurchase of Common Stock	0	(111,371)
Payments of Financing Costs	(5,323)	(7,798)
Payment, Tax Withholding, Share-Based Payment Arrangement	(6,155)	(8,438)
Payments to Noncontrolling Interests	(2,360)	(4,621)
Proceeds from Noncontrolling Interests	0	9,343
Net Change Interest-Bearing Deposits, Foreign	(7,747)	(13,732)
Net Cash Provided by (Used in) Financing Activities, Total	328,251	(190,054)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	3,270	(31,927)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	33,660	(29,989)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance	84,758	89,072
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Ending Balance	118,418	59,083
Supplemental Cash Flow Information [Abstract]
Interest Paid, Excluding Capitalized Interest, Operating Activities	111,344	87,912
Income Taxes Paid	28,479	21,086
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]
Cash and Cash Equivalents, at Carrying Value	105,172	57,991
Restricted Cash and Cash Equivalents	13,246	1,092
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	$ 118,418	$ 59,083

Organization and Business

Organization and Business	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business	Organization and Business: Nature of operations : As used herein, the terms "PRA Group," the "Company," or similar terms refer to PRA Group, Inc. and its subsidiaries. PRA Group, Inc., a Delaware corporation, is a global financial and business services company with operations in the Americas, Europe and Australia. The Company's primary business is the purchase, collection and management of portfolios of nonperforming loans. The Company also provides fee-based services on class action claims recoveries and by servicing consumer bankruptcy accounts in the United States ("U.S."). Basis of presentation : The Consolidated Financial Statements of the Company are prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). The accompanying interim financial statements have been prepared in accordance with the instructions for Quarterly Reports on Form 10-Q and, therefore, do not include all information and Notes to the Consolidated Financial Statements necessary for a complete presentation of financial position, results of operations, comprehensive income/(loss) and cash flows in conformity with GAAP. In the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair presentation of the Company's Consolidated Balance Sheets as of September 30, 2023, its Consolidated Income Statements and Statements of Comprehensive Income for the three and nine months ended September 30, 2023 and 2022, and its Consolidated Statements of Changes in Equity and Statements of Cash Flows for the nine months ended September 30, 2023 and 2022, have been included. The Company's Consolidated Income Statements for the three and nine months ended September 30, 2023 may not be indicative of future results. These unaudited Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022 (the "2022 Form 10-K"). Reclassification of prior year presentation : Certain prior year amounts have been reclassified for consistency with the current year presentation. Fee income is now included within Other revenue on the Consolidated Income Statements. Consolidation : The Consolidated Financial Statements include the accounts of PRA Group and other entities in which the Company has a controlling interest. All significant intercompany accounts and transactions have been eliminated. Entities in which the Company has a controlling financial interest, through ownership of the majority of the entities’ voting equity interests, or through other contractual rights that give the Company control, consist of entities which purchase and collect on portfolios of nonperforming loans. Investments in companies in which the Company has significant influence over operating and financing decisions, but does not own a majority of the voting equity interests or exercise control, are accounted for in accordance with the equity method of accounting, which requires the Company to recognize its proportionate share of the entity's net earnings. Income or loss from these investments is included in Other revenue. The Company performs on-going reassessments of whether changes in facts and circumstances regarding the Company’s involvement with an entity would cause the Company’s consolidation conclusions to change. Segments : The Company has determined that it has two operating segments that meet the aggregation criteria of Accounting Standards Codification ("ASC") 280, Segment Reporting ("ASC 280") and, therefore, it has one reportable segment; accounts receivable management. This conclusion is based on similarities among the operating units, including economic characteristics, the nature of the products and services, the nature of the production processes, the types or class of customer for their products and services, the methods used to distribute their products and services and the nature of the regulatory environment. Revenues and long-lived assets by geographical location: Revenues for the three and nine months ended September 30, 2023 and 2022, and long-lived assets held as of September 30, 2023 and 2022, both for the U.S., the Company's country of domicile, and outside of the U.S., were as follows (amounts in thousands): As of and for the As of and for the Three Months Ended September 30, 2023 Three Months Ended September 30, 2022 Revenues (2) Long-Lived Assets Revenues (2) Long-Lived Assets U.S. $ 105,456 $ 61,788 $ 138,398 $ 80,496 United Kingdom 30,978 11,233 37,032 10,762 Brazil 24,749 3 14,293 3 Other (1) 55,247 12,694 55,084 13,448 Total $ 216,430 $ 85,718 $ 244,807 $ 104,709 As of and for the As of and for the Nine Months Ended September 30, 2023 Nine Months Ended September 30, 2022 Revenues (2) Long-Lived Assets Revenues (2) Long-Lived Assets U.S. $ 258,848 $ 61,788 $ 426,675 $ 80,496 United Kingdom 99,547 11,233 126,866 10,762 Brazil 69,383 3 22,629 3 Other (1) 153,358 12,694 167,504 13,448 Total $ 581,136 $ 85,718 $ 743,674 $ 104,709 (1) None of the countries included in "Other" comprise greater than 10% of the Company's consolidated revenues or long-lived assets. (2) Based on the Company’s financial statement information used to produce the Company's general-purpose financial statements, it is impracticable to report further breakdowns of revenues from external customers by product or service.

Finance Receivables, net

Finance Receivables, net	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Receivables [Abstract]
Finance Receivables, net	and 2022 Changes in the negative allowance for expected recoveries by portfolio segment for the nine months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Nine Months Ended September 30, 2023 Core Insolvency Total Balance at beginning of period $ 2,936,207 $ 358,801 $ 3,295,008 Initial negative allowance for expected recoveries - portfolio acquisitions (1) 763,776 105,391 869,167 Foreign currency translation adjustment (15,662) 1,296 (14,366) Recoveries applied to negative allowance (2) (574,993) (120,392) (695,385) Changes in expected recoveries (3) (7,436) 13,816 6,380 Balance at end of period $ 3,101,892 $ 358,912 $ 3,460,804 Nine Months Ended September 30, 2022 Core Insolvency Total Balance at beginning of period $ 2,989,932 $ 438,353 $ 3,428,285 Initial negative allowance for expected recoveries - portfolio acquisitions (1) 513,385 48,516 561,901 Foreign currency translation adjustment (287,901) (34,010) (321,911) Recoveries applied to negative allowance (2) (628,293) (137,439) (765,732) Changes in expected recoveries (3) 107,155 27,662 134,817 Balance at end of period $ 2,694,278 $ 343,082 $ 3,037,360 (1) Initial negative allowance for expected recoveries - portfolio acquisitions Portfolio acquisitions for the nine months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Nine Months Ended September 30, 2023 Core Insolvency Total Face value $ 5,717,674 $ 579,113 $ 6,296,787 Noncredit discount (600,174) (38,621) (638,795) Allowance for credit losses at acquisition (4,353,724) (435,101) (4,788,825) Purchase price $ 763,776 $ 105,391 $ 869,167 Nine Months Ended September 30, 2022 Core Insolvency Total Face value $ 3,539,705 $ 256,528 $ 3,796,233 Noncredit discount (363,138) (16,976) (380,114) Allowance for credit losses at acquisition (2,663,182) (191,036) (2,854,218) Purchase price $ 513,385 $ 48,516 $ 561,901 The initial negative allowance recorded on portfolio acquisitions for the nine months ended September 30, 2023 and 2022 was as follows (amounts in thousands): Nine Months Ended September 30, 2023 Core Insolvency Total Allowance for credit losses at acquisition $ (4,353,724) $ (435,101) $ (4,788,825) Writeoffs, net 4,353,724 435,101 4,788,825 Expected recoveries 763,776 105,391 869,167 Initial negative allowance for expected recoveries $ 763,776 $ 105,391 $ 869,167 Nine Months Ended September 30, 2022 Core Insolvency Total Allowance for credit losses at acquisition $ (2,663,182) $ (191,036) $ (2,854,218) Writeoffs, net 2,663,182 191,036 2,854,218 Expected recoveries 513,385 48,516 561,901 Initial negative allowance for expected recoveries $ 513,385 $ 48,516 $ 561,901 (2) Recoveries applied to negative allowance Recoveries applied to the negative allowance for the nine months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Nine Months Ended September 30, 2023 Core Insolvency Total Recoveries (a) $ 1,106,799 $ 151,078 $ 1,257,877 Less - amounts reclassified to portfolio income 531,806 30,686 562,492 Recoveries applied to negative allowance $ 574,993 $ 120,392 $ 695,385 Nine Months Ended September 30, 2022 Core Insolvency Total Recoveries (a) $ 1,179,746 $ 173,380 $ 1,353,126 Less - amounts reclassified to portfolio income 551,453 35,941 587,394 Recoveries applied to negative allowance $ 628,293 $ 137,439 $ 765,732 (a) Recoveries include cash collections, buybacks and other cash-based adjustments. (3) Changes in expected recoveries Changes in expected recoveries for the nine months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Nine Months Ended September 30, 2023 Core Insolvency Total Changes in expected future recoveries $ (40,919) $ 23 $ (40,896) Recoveries received in excess of forecast 33,483 13,793 47,276 Changes in expected recoveries $ (7,436) $ 13,816 $ 6,380 Nine Months Ended September 30, 2022 Core Insolvency Total Changes in expected future recoveries $ 43,262 $ 3,894 $ 47,156 Recoveries received in excess of forecast 63,893 23,768 87,661 Changes in expected recoveries $ 107,155 $ 27,662 $ 134,817	Finance Receivables, net: Finance receivables, net consisted of the following at September 30, 2023 and December 31, 2022 (amounts in thousands): September 30, 2023 December 31, 2022 Amortized cost $ — $ — Negative allowance for expected recoveries 3,460,804 3,295,008 Balance at end of period $ 3,460,804 $ 3,295,008 Three Months Ended September 30, 2023 and 2022 Changes in the negative allowance for expected recoveries by portfolio segment for the three months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Three Months Ended September 30, 2023 Core Insolvency Total Balance at beginning of period $ 3,086,405 $ 338,143 $ 3,424,548 Initial negative allowance for expected recoveries - portfolio acquisitions (1) 248,181 63,002 311,183 Foreign currency translation adjustment (58,878) (6,786) (65,664) Recoveries applied to negative allowance (2) (189,710) (41,709) (231,419) Changes in expected recoveries (3) 15,894 6,262 22,156 Balance at end of period $ 3,101,892 $ 358,912 $ 3,460,804 Three Months Ended September 30, 2022 Core Insolvency Total Balance at beginning of period $ 2,814,761 $ 368,871 $ 3,183,632 Initial negative allowance for expected recoveries - portfolio acquisitions (1) 160,206 22,898 183,104 Foreign currency translation adjustment (133,263) (14,254) (147,517) Recoveries applied to negative allowance (2) (186,112) (44,083) (230,195) Changes in expected recoveries (3) 38,686 9,650 48,336 Balance at end of period $ 2,694,278 $ 343,082 $ 3,037,360 (1) Initial negative allowance for expected recoveries - portfolio acquisitions Portfolio acquisitions for the three months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Three Months Ended September 30, 2023 Core Insolvency Total Face value $ 1,992,448 $ 382,363 $ 2,374,811 Noncredit discount (209,131) (23,837) (232,968) Allowance for credit losses at acquisition (1,535,136) (295,524) (1,830,660) Purchase price $ 248,181 $ 63,002 $ 311,183 Three Months Ended September 30, 2022 Core Insolvency Total Face value $ 1,482,758 $ 123,369 $ 1,606,127 Noncredit discount (126,205) (7,874) (134,079) Allowance for credit losses at acquisition (1,196,347) (92,597) (1,288,944) Purchase price $ 160,206 $ 22,898 $ 183,104 The initial negative allowance recorded on portfolio acquisitions for the three months ended September 30, 2023 and 2022 was as follows (amounts in thousands): Three Months Ended September 30, 2023 Core Insolvency Total Allowance for credit losses at acquisition $ (1,535,136) $ (295,524) $ (1,830,660) Writeoffs, net 1,535,136 295,524 1,830,660 Expected recoveries 248,181 63,002 311,183 Initial negative allowance for expected recoveries $ 248,181 $ 63,002 $ 311,183 Three Months Ended September 30, 2022 Core Insolvency Total Allowance for credit losses at acquisition $ (1,196,347) $ (92,597) $ (1,288,944) Writeoffs, net 1,196,347 92,597 1,288,944 Expected recoveries 160,206 22,898 183,104 Initial negative allowance for expected recoveries $ 160,206 $ 22,898 $ 183,104 (2) Recoveries applied to negative allowance Recoveries applied to the negative allowance for the three months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Three Months Ended September 30, 2023 Core Insolvency Total Recoveries (a) $ 369,385 $ 51,994 $ 421,379 Less - amounts reclassified to portfolio income 179,675 10,285 189,960 Recoveries applied to negative allowance $ 189,710 $ 41,709 $ 231,419 Three Months Ended September 30, 2022 Core Insolvency Total Recoveries (a) $ 361,089 $ 54,959 $ 416,048 Less - amounts reclassified to portfolio income 174,977 10,876 185,853 Recoveries applied to negative allowance $ 186,112 $ 44,083 $ 230,195 (a) Recoveries include cash collections, buybacks and other cash-based adjustments. (3) Changes in expected recoveries Changes in expected recoveries for the three months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Three Months Ended September 30, 2023 Core Insolvency Total Changes in expected future recoveries $ 4,234 $ (168) $ 4,066 Recoveries received in excess of forecast 11,660 6,430 18,090 Changes in expected recoveries $ 15,894 $ 6,262 $ 22,156 Three Months Ended September 30, 2022 Core Insolvency Total Changes in expected future recoveries $ 17,851 $ 2,361 $ 20,212 Recoveries received in excess of forecast 20,835 7,289 28,124 Changes in expected recoveries $ 38,686 $ 9,650 $ 48,336 In order to estimate future cash collections, the Company considers historical performance and current economic forecasts, as well as expectations for short-term and long-term growth and consumer habits in the various geographies in which the Company operates. The Company considers recent collection activity in its determination to adjust assumptions related to estimated remaining collections ("ERC") for certain pools. Based on these considerations, the Company’s estimates of ERC incorporate changes in both amounts and in the timing of expected cash collections over the forecast period. Changes in expected recoveries for the three months ended September 30, 2023 were a net positive $22.2 million. This includes $18.1 million in recoveries received in excess of forecast (cash collections overperformance) and a $4.1 million positive adjustment to changes in expected future recoveries. The $18.1 million in recoveries received in excess of forecast reflected overperformance in Europe and the Americas. Changes in expected recoveries for the three months ended September 30, 2022 were a net positive $48.3 million. This reflected $28.1 million in recoveries received in excess of forecast reflecting cash collections overperformance and a $20.2 million positive adjustment to changes in expected future recoveries. The changes in expected future recoveries reflected the Company's assessment of certain pools, where continued strong performance resulted in an increase to the Company's ERC.

Investments

Investments	9 Months Ended
	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Investments	Investments: Investments consisted of the following at September 30, 2023 and December 31, 2022 (amounts in thousands): September 30, 2023 December 31, 2022 Debt securities Available-for-sale $ 62,755 $ 66,813 Equity securities Private equity funds 2,911 4,373 Equity method investments 9,063 8,762 Total investments $ 74,729 $ 79,948 Debt Securities Available-for-sale Government securities: The Company's investments in government instruments, including Norwegian bonds and Swedish treasury s ecurities, are classified as available-for-sale and stated at fair value. At September 30, 2023, maturities for these securities were $58.8 million due within one year and $3.9 million due within one to two years. The amortized cost and fair value of investments in debt securities at September 30, 2023 and December 31, 2022 was as follows (amounts in thousands): September 30, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized (Losses) Aggregate Fair Value Available-for-sale Government securities $ 62,969 $ 36 $ (250) $ 62,755 December 31, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized (Losses) Aggregate Fair Value Available-for-sale Government securities $ 67,049 $ 1 $ (237) $ 66,813 Equity Securities Private equity funds: Investments in private equity funds represent limited partnerships in which the Company has less tha n a 1% interest. Equity Method Investments The Company ha s an 11.7% interest in RC B Investimentos S.A. ("RCB"), a servicing platform for nonperforming loans in Brazil. This investment is accounted for under the equity method because the Company exercises significant influence over RCB’s operating and financial activities. Accordingly, the Company’s investment in RCB is adjusted for the Company’s proportionate share of RCB’s earnings or losses, capital contributions made and distributions received.

Goodwill

Goodwill	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill: The Company performs an annual review of goodwill as of October 1 of each year or more frequently if indicators of impairment exist. The Company performed its most recent annual review as of October 1, 2022 and concluded that goodwill was not impaired. The Company performed a quarterly impairment assessment by evaluating whether any triggering events had occurred, which included considering current market conditions, and determined that goodwill was not more likely than not impaired as of September 30, 2023. Changes in goodwill for the three and nine months ended September 30, 2023 and 2022, were as follows (amounts in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Balance at beginning of period $ 414,905 $ 437,032 $ 435,921 $ 480,263 Change in foreign currency translation adjustment (2,392) (32,558) (23,408) (75,789) Balance at end of period $ 412,513 $ 404,474 $ 412,513 $ 404,474

Leases

Leases	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Leases	Leases: The Company's operating lease portfolio primarily includes corporate offices and call centers. The majority of its leases have remaining lease terms of one me of which include options to extend the leases for up to five years, and others include options to terminate the leases within one year. Exercises of lease renewal options are typically at the Company's sole discretion, with renewal periods included in ROU assets and lease liabilities based upon whether the Company is reasonably certain of exercising the renewal options. The Company has lease agreements with lease and non-lease components, which are generally accounted for separately. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments. The components of lease expense for the three and nine months ended September 30, 2023 and 2022, were as follows (amounts in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Operating lease expense $ 2,617 $ 2,775 $ 8,132 $ 9,095 Short-term lease expense 526 775 1,553 1,874 Sublease income (21) (118) (296) (348) Total lease expense $ 3,122 $ 3,432 $ 9,389 $ 10,621 Supplemental cash flow information and non-cash activity related to leases for the nine months ended September 30, 2023 and 2022 was as follows (amounts in thousands): Nine Months Ended September 30, 2023 2022 Cash paid for amounts included in the measurement of operating lease liabilities $ 8,806 $ 8,923 ROU assets obtained in exchange for operating lease obligations (1) 2,663 5,910 (1) Includes the impact of new leases as well as remeasurements and modifications to existing leases. Lease term and discount rate information related to operating leases was as follows: Nine Months Ended September 30, 2023 2022 Weighted-average remaining lease term (years) 7.1 8.2 Weighted-average discount rate 4.65 % 4.48 % Maturities of lease liabilities at September 30, 2023 were as follows for the following periods (amounts in thousands): Operating Leases For the three months ending December 31, 2023 $ 2,600 For the year ending December 31, 2024 9,879 For the year ending December 31, 2025 9,608 For the year ending December 31, 2026 8,490 For the year ending December 31, 2027 5,724 Thereafter 25,391 Total lease payments 61,692 Less: imputed interest (10,034) Total present value of lease liabilities $ 51,658

Borrowings

Borrowings	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Borrowings	Borrowings: The Company's borrowings consisted of the following as of September 30, 2023 and December 31, 2022 (amounts in thousands): September 30, 2023 December 31, 2022 Americas revolving credit (1) $ 382,351 $ 186,867 UK revolving credit 500,257 453,528 Europe revolving credit 473,873 419,856 Term loan 442,500 450,000 Senior notes 1,046,000 650,000 Convertible notes — 345,000 2,844,981 2,505,251 Less: Debt discount and issuance costs (12,756) (10,393) Total $ 2,832,225 $ 2,494,858 (1) Includes the North American revolving credit facility and an unsecured credit agreement with Banco de Occidente (the "Colombian Revolving Credit Facility"). As of September 30, 2023, no amounts were outstanding under the Colombian Revolving Credit Facility ($0.5 million was outstanding as of December 31, 2022). The following principal payments are due on the Company's borrowings as of September 30, 2023 for the 12-month periods ending September 30, (amounts in thousands): 2024 $ 10,000 2025 308,000 2026 1,305,108 2027 — 2028 871,873 Thereafter 350,000 Total $ 2,844,981 During the nine months ended September 30, 2023, the Company repurchased a total of $4.0 million in aggregate principal amount of the senior notes. The Company determined that it was in compliance with the covenants of its financing arrangements as of September 30, 2023. North American Revolving Credit and Term Loan The Company has a credit agreement with Bank of America, N.A., as administrative agent, Bank of America, National Association, acting through its Canada branch, as the Canadian Administrative Agent, and a syndicate of lenders named therein (the "North American Credit Agreement"). The total credit facility under the North American Credit Agreement includes an aggregate principal amount of $1.5 billion (subject to compliance with a borrowing base and applicable debt covenants), which consists of (i) a fully-funded $442.5 million term loan, (ii) a $1.0 billion domestic revolving credit facility, and (iii) a $75.0 million Canadian revolving credit facility. The facility includes an accordion feature for up to $500.0 million in additional commitments (at the option of the lenders) and also provides for up to $25.0 million of letters of credit and a $25.0 million swingline loan sub-limit that would reduce amounts available for borrowin g. With the official discontinuation of the London Interbank Offered Rate ("LIBOR") on June 30, 2023, the Company executed an amendment to its North American Credit Agreement to allow for previously outstanding LIBOR borrowings and subsequent borrowings to use the Secured Overnight Financing Rate ("SOFR"). The term and revolving loans accrue interest, at the option of the Company, at either the base rate, Canadian dollar offered rate or SOFR for the applicable term, plus 2.25% plus a 0.10% credit adjustment spread, or 2.00% plus a 0.10% credit adjustment spread if the consolidated senior secured leverage ratio is less than or equal to 1.60 to 1.0. The revolving loans within the credit facility are subject to a 0% floor. The revolving credit facilities also bear an unused line fee of 0.35% per annum, or 0.30% if the consolidated senior secured leverage ratio is less than or equal to 1.60 to 1.0, payable quarterly in arrears a nd matures July 30, 2026. As of September 30, 2023, total availability under the North American Credit Agreement was $692.6 million, which was comprised of $70.3 million based on current ERC, and $622.3 million additional availability subject to debt covenants, including advance rates. Borrowings under the North American Credit Agreement are guaranteed by the Company's U.S. and Canadian subsidiaries (provided that the Canadian subsidiaries only guarantee borrowings under the Canadian revolving credit facility) and are secured by a first priority lien on substantially all of the Company's assets. The North American Credit Agreement contains events of default and restrictive covenants, including the following: • the ERC borrowing base is 35% for all eligible core asset pools and 55% for all insolvency eligible asset pools; • the Company's consolidated total leverage ratio cannot exceed 3.50 to 1.0 as of the end of any fiscal quarter; • the Company's consolidated senior secured leverage ratio cannot exceed 2.25 to 1.0 as of the end of any fiscal quarter; • subject to no default or event of default, cash dividends and distributions during any fiscal year cannot exceed $20.0 million; and • the Company must maintain positive consolidated income from operations during any fiscal quarter (other than for the quarter ended March 31, 2023). United Kingdom ("UK") Revolving Credit Facility PRA Group Europe Holding I S.a.r.l ("PRA Group Europe"), a wholly owned subsidiary of the Company, along with PRA Group UK Limited ("PRA UK") and the Company, as guarantors, are parties to a credit agreement (the "UK Credit Agreement") with the lenders party thereto and MUFG Bank, Ltd., London Branch, as the administrative agent (the "Administrative Agent"). The UK Credit Agreement consists of an $800.0 million revolving credit facility (subject to a borrowing base), and an accordion feature for up to $200.0 million in additional commitments, subject to certain conditions. Borrowings, which are available in U.S. dollars, euro and pounds sterling accrue interest for the applicable term at SOFR, Sterling Overnight Index Average ("SONIA") or, in the case of euro borrowings, the Euro Interbank Offered Rate ("Euribor") plus an applicable margin of 2.75% per annum plus a 0.10% credit adjustment spread, or 2.50% plus a 0.10% credit adjustment spread if the consolidated senior secured leverage ratio is less than 1.60 to 1.0. The UK Credit Agreement also has a commitment fee of 0.30% per annum, payable quarterly in arrears. If the consolidated senior secured leverage ratio is greater than 1.60 to 1.0, the commitment fee increases to 0.35% per annum. The UK Credit Agreement matures on July 30, 2026. As of September 30, 2023, total availability under the UK Credit Agreement was $299.7 million, which was comprised of $57.4 million based on current ERC, and $242.3 million additional availability subject to debt covenants, including advance rates. The UK Credit Agreement is secured by substantially all of the assets of PRA UK, all of the equity interests in PRA UK and certain equity interests of PRA Group Europe, certain bank accounts of PRA Group Europe and certain intercompany loans extended by PRA Group Europe to PRA UK. The UK Credit Agreement contains events of default and restrictive covenants, including the following: • the borrowing base equals the sum of up to: (i) 35% of the ERC of PRA UK’s eligible asset pools; plus (ii) 55% of PRA UK’s insolvency eligible asset pools; minus (iii) certain reserves to be established by the Administrative Agent; • the Company's consolidated leverage ratio cannot exceed 3.50 to 1.0 as of the end of any fiscal quarter; • the Company's consolidated senior secured leverage ratio cannot exceed 2.25 to 1.0 as of the end of any fiscal quarter; and • the Company must maintain positive consolidated income from operations during any fiscal quarter (other than for the quarter ended March 31, 2023). European Revolving Credit Facility The Company's wholly-owned subsidiary, PRA Group Europe Holding S.a.r.l. ("PRA Group Europe Holding"), and its Swiss Branch, PRA Group Europe Holding S.a.r.l. ("PRA Group Holding"), Luxembourg, Zug Branch (together, the "Borrowers"), along with certain of its affiliates and the Company, as guarantors, are parties to a credit agreement (the "European Credit Agreement") with the lenders party thereto and DNB Bank ASA as facility agent and security agent (the "Agent"). The European Credit Agreement provides borrowings for an aggregate amount of approximately €730.0 million (subject to the borrowing base) and an uncommitted accordion feature for up to €500.0 million, subject to certain conditions. Borrowings, which are available in euro, Norwegian krone, Danish krone, Swedish krona, and Polish zloty, accrue interest at the Interbank Offered Rate plus 2.80% - 3.80% (as determined by the estimated remaining collections ratio ("ERC Ratio") as defined in the European Credit Agreement), bear an unused line fee, currently 1.085% per annum, or 35% of the margin, are subject to a 0% floor, are payable monthly in arrears and mature November 23, 2027. Additionally, the Company has a separate agreement with the Agent for an overdraft facility in the aggregate amount of $40.0 million (subject to the borrowing base), which accrues interest (per currency) at the daily rates as published by the Agent, bears a facility line fee of 0.125% per quarter, payable quarterly in arrears and matures November 23, 2027. As of September 30, 2023, total availability under the European Credit Agreement (including the overdraft facility) was $337.9 million, which was comprised of $150.1 million based on current ERC, and $187.8 million additional availability subject to debt covenants, including advance rates. The European Credit Agreemen t is secured by a first perfected security interest in all of the equity interests in certain operating subsidiaries of the Borrowers, certain intercompany loans and certain shareholder loans extended by the Company to the Borrowers. Further, the Company guarantees all obligations and liabilities under the European Credit Agreement. The European Credit Agreement contains event of default and restrictive covenants including the following: • the ERC Ratio cannot exceed 45%; • the Company's consolidated total leverage ratio cannot exceed 3.50 to 1.0 as of the end of any fiscal quarter; • the Company's consolidated senior secured leverage ratio cannot exceed 2.25 to 1.0 as of the end of any fiscal quarter; • the Company must maintain positive consolidated income from operations at the end of any fiscal quarter (other than for the quarter ended March 31, 2023); • interest bearing deposits in AK Nordic AB cannot exceed SEK 1.2 billion; and • PRA Europe's cash collections must meet certain thresholds, measured on a quarterly basis. Senior Notes due 2029 On September 22, 2021, the Company completed the private offering of $350.0 million in aggregate principal amount of its 5.00% Senior Notes due October 1, 2029 (the "2029 Notes"). The 2029 Notes were issued pursuant to an Indenture dated September 22, 2021 (the "2021 Indenture"), between the Company and Regions Bank, as trustee. The 2021 Indenture contains customary terms and covenants, including certain events of default after which the 2029 Notes may be due and payable immediately. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by all of the Company's existing and future domestic restricted subsidiaries that guarantee the North American Credit Agreement, subject to certain exceptions. Interest on the 2029 Notes is payable semi-annually, in arrears, on October 1 and April 1 of each year. On or before October 1, 2024, the Company may redeem up to 40% of the aggregate principal amount of the 2029 Notes at a redemption price of 105.00% plus accrued and unpaid interest with the net cash proceeds of a public offering of common stock of the Company provided, that at least 60% in aggregate principal amount of the 2029 Notes remains outstanding immediately after the occurrence of such redemption and that such redemption will occur within 90 days of the date of the closing of such public offering. In ad dition, on or after October 1, 2024, the 2029 Notes may be redeemed, at the Company's option, in whole or in part at a price equal to 102.50% of the aggregate principal amount of the 2029 Notes being redeemed. The applicable redemption price changes if redeemed during the 12 months beginning October 1 of each year to 101.25% for 2025 and then 100% for 2026 and thereafter. In the event of a change of control, each holder will have the right to require the Company to repurchase all or any part of such holder's 2029 Notes at an offer price equal to 101% of the aggregate principal amount plus accrued and unpaid interest. If the Company sells assets under certain circumstances and does not use the proceeds for specified purposes, the Company will be required to make an offer to repurchase the 2029 Notes at 100% of their principal amount plus accrued and unpaid interest. Senior Notes due 2028 On February 6, 2023, the Company completed the private offering of $400.0 million aggregate principal amount of its 8.375% Senior Notes due 2028 ("2028 Notes"). The 2028 Notes were issued pursuant to an Indenture dated February 6, 2023 (the "2023 Indenture"), between the Company and Regions Bank, as trustee. The 2023 Indenture contains customary terms and covenants, including certain events of default after which the 2028 Notes may be due and payable immediately. The 2028 Notes are senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by all of the Company's e xisting and future domestic restricted subsidiaries that guarantee the North American Credit Agreement, subject to certain exceptions. Interest on the 2028 Notes is payable semi-annually, in arrears, on February 1 and August 1 of each year. Substantially all of the net proceeds received from the 2028 Notes were used to retire the 2023 Notes (as defined below). The Company used the remainder of the net proceeds to repay a portion of its outstanding borrowings under the domestic revolving credit facility under the North America Credit Agreement. On or before February 1, 2025, the Company may redeem up to an aggregate of 40% of the aggregate principal amount of the 2028 Notes at a redemption price of 108.375% plus accrued and unpaid interest with the net cash proceeds of a public offering of common stock of the Company, provided that at least 60% in aggregate principal amount of the 2028 Notes remains outstanding immediately after the occurrence of such redemption and that such redemption will occur within 90 days of the date of the closing of such public offering. In addition, on or after February 1, 2025, t he 2028 Notes may be redeemed at the Company's option in whole or in part at a price equal to 104.188% of the aggregate principal amount of the 2028 Notes being redeemed. The applicable redemption price changes if redeemed during the 12 months beginning February 1 of each year to 102.094% for 2026 and then 100% for 2027 and thereafter. In the event of a change of control, each holder will have the right to require the Company to repurchase all or any part of such holder's 2028 Notes at an offer price equal to 101% of the aggregate principal amount plus accrued and unpaid interest. If the Company sells assets under certain circumstances and does not use the proceeds for specified purposes, the Company will be required to make an offer to repurchase the 2028 Notes at 100% of their principal amount plus accrued and unpaid interest. During the nine months ended September 30, 2023, the Company repurchased $2.0 million in aggregate principal amount of the 2028 Notes. Senior Notes due 2025 On August 27, 2020, the Company completed the private offering of $300.0 million in aggregate principal amount of its 7.375% Senior Notes due September 1, 2025 (the "2025 Notes" and, together with the 2029 Notes and the 2028 Notes, the "Senior Notes"). The 2025 Notes were issued pursuant to an Indenture dated August 27, 2020 (the "2020 Indenture"), between the Company and Regions Bank, as trustee. The 2020 Indenture contains customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately. The 2025 Notes are senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by all of the Company's existing and future domestic restricted subsidiaries that guarantee the North American Credit Agreement, subject to certain exceptions. Interest on the 2025 Notes is payable semi-annually, in arrears, on March 1 and September 1 of each year. The 2025 Notes may be redeemed, at the Company's option, in whole or in part, at a price equal to 103.688% of the aggregate principal amount of the 2025 Notes being redeemed. The applicable redemption price changes if redeemed during the 12 months beginning September 1 of each year to 101.844% for 2023 and then 100% for 2024 and thereafter. In the event of a change of control, each holder will have the right to require the Company to repurchase all or any part of such holder's 2025 Notes at a price equal to 101% of their aggregate principal amount, plus accrued and unpaid interest. If the Company sells assets under certain circumstances and does not use the proceeds for specified purposes, the Company will be required to make an offer to repurchase the 2025 Notes at 100% of their principal amount plus accrued and unpaid interest. During the nine months ended September 30, 2023, the Company repurchased $2.0 million in aggregate principal amount of the 2025 Notes. Convertible Senior Notes due 2023 The Company used substantially all of the net proceeds from the issuance of the 2028 Notes to retire the $345.0 million aggregate principal amount of its 3.50% Convertible Senior Notes at their maturity on June 1, 2023 (the "2023 Notes"). Interest expense on the 2023 Notes was recognized using an effective interest rate of 4.00%, and for the three and nine months ended September 30, 2023 and 2022, was as follows (amounts in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Interest expense - stated coupon rate $ — $ 3,019 $ 5,032 $ 9,057 Interest expense - amortization of debt issuance costs — 429 748 1,284 Total interest expense - convertible notes $ — $ 3,448 $ 5,780 $ 10,341

Derivatives

Derivatives	9 Months Ended
	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	Derivatives: The Company periodically enters into derivative financial instruments; typically interest rate swaps, interest rate caps and foreign currency contracts, to reduce its exposure to fluctuations in interest rates on variable-rate debt and foreign currency exchange rates. The Company does not utilize derivative financial instruments with a level of complexity or with a risk greater than the exposure to be managed, nor does it enter into or hold derivatives for trading or speculative purposes. The Company periodically reviews the creditworthiness of the counterparty to assess the counterparty's ability to honor its obligations. Counterparty default would expose the Company to fluctuations in interest and currency rates. Derivative financial instruments are recognized at fair value in the Company's Consolidated Balance Sheets. The following table summarizes the fair value of derivative instruments as of September 30, 2023 and December 31, 2022 (amounts in thousands): September 30, 2023 December 31, 2022 Balance Sheet Location Fair Value Balance Sheet Location Fair Value Derivatives designated as hedging instruments: Interest rate contracts Other assets $ 32,482 Other assets $ 37,305 Interest rate contracts Other liabilities 3,195 Other liabilities — Derivatives not designated as hedging instruments: Foreign currency contracts Other assets 10,380 Other assets 487 Foreign currency contracts Other liabilities 206 Other liabilities 19,120 Derivatives Designated as Hedging Instruments: Changes in fair value of derivative contracts designated as cash flow hedging instruments are recognized in other comprehensive income ("OCI"). As of September 30, 2023 and December 31, 2022, the notional amount of interest rate contracts designated as cash flow hedging instruments w as $878.2 million and $719.7 million, respectively. Derivatives designated as cash flow hedging instruments were evaluated and remained highly effective at September 30, 2023 and have remaining terms of three months to five years. The Co mpany estimates that approxi mately $16.6 million of net derivative gains included in OCI w ill be reclassified into earnings within the next 12 months. The following tables summarize the effects of derivatives designated as cash flow hedging instruments on the Company's Consolidated Financial Statements for the three and nine months ended September 30, 2023 and 2022 (amounts in thousands): Gain/(loss) recognized in OCI, net of tax Three Months Ended September 30, Nine Months Ended September 30, Derivatives designated as cash flow hedging instruments 2023 2022 2023 2022 Interest rate contracts $ (2,712) $ 19,983 $ 7,430 $ 41,106 Gain/(loss) reclassified from OCI into income Three Months Ended September 30, Nine Months Ended September 30, Location of gain/(loss) reclassified from OCI into income 2023 2022 2023 2022 Interest expense, net $ 6,498 $ 383 $ 18,666 $ (3,819) During the three months ended September 30, 2023, with the discontinuation of LIBOR on June 30, 2023, and transition of the Company's interest rate swaps from LIBOR to SOFR, the Company discontinued the prior elections under ASU 2021-01, "Reference Rate Reform (Topic 848): Overall" ("ASU 2021-01"). Derivatives Not Designated as Hedging Instruments: The Company enters into foreign currency contracts to economically hedge foreign currency re-measurement exposure related to certain balances denominated in currencies other than the functional currency of the entity. Changes in fair value of derivative contracts not designated as hedging instruments are recognized in earnings. As of September 30, 2023 and December 31, 2022, the notional amount of foreign currency contracts w as $412.0 million and $460.8 million , respectively. The following table summarizes the effects of derivatives not designated as hedging instruments on the Company's Consolidated Income Statements for the three and nine months ended September 30, 2023 and 2022 (amounts in thousands): Gain/(loss) recognized in income Three Months Ended September 30, Derivatives not designated as hedging instruments Location of gain/(loss) recognized in income 2023 2022 Foreign currency contracts Foreign exchange gain, net $ 8,137 $ 33,019 Foreign currency contracts Interest expense, net 204 313 Gain/(loss) recognized in income Nine Months Ended September 30, Derivatives not designated as hedging instruments Location of gain/(loss) recognized in income 2023 2022 Foreign currency contracts Foreign exchange gain/(loss), net $ (7,149) $ 72,371 Foreign currency contracts Interest expense, net 1,357 (638)

Fair Value Measurements and Dis

Fair Value Measurements and Disclosures	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value	Fair Value: As defined by ASC Topic 820, "Fair Value Measurement and Disclosures" ("ASC 820"), fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 requires the consideration of different input levels in the determination of fair value, as follows: • Level 1: Quoted prices in active markets for identical assets and liabilities. • Level 2: Observable inputs other than Level 1 quoted prices, such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. • Level 3: Unobservable inputs that are supported by little or no market activity. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety. Financial Instruments Not Carried at Fair Value In accordance with the disclosure requirements of ASC Topic 825, "Financial Instruments" ("ASC 825"), the table below summarizes fair value estimates for the Company's financial instruments that are not carried at fair value. The total of the fair values presented does not represent, and should not be construed to represent, the underlying value of the Company. The carrying amounts in the table below were recorded in the Company's Consolidated Balance Sheets at September 30, 2023 and December 31, 2022 (amounts in thousands): September 30, 2023 December 31, 2022 Carrying Estimated Carrying Estimated Financial assets: Cash and cash equivalents $ 105,172 $ 105,172 $ 83,376 $ 83,376 Finance receivables, net 3,460,804 3,005,033 3,295,008 3,167,813 Financial liabilities: Interest-bearing deposits 100,505 100,505 112,992 112,992 Revolving lines of credit 1,356,481 1,356,481 1,060,251 1,060,251 Term loan 442,500 442,500 450,000 450,000 Senior notes 1,046,000 923,125 650,000 580,433 Convertible notes — — 345,000 341,926 Disclosure of the estimated fair values of financial instruments often requires the use of estimates. The carrying amount and estimates of the fair value of the Company's debt obligations outlined above do not include any related debt issuance costs associated with the debt obligations. The Company uses the following methods and assumptions to estimate the fair value of financial instruments: Cash equivalents: The carrying amount approximates fair value due to the short-term nature of the instruments and the observable quoted prices for identical assets in active markets. Accordingly, the Company uses Level 1 inputs for its fair value estimates. Finance receivables, net: The Company estimates the fair value of these receivables using proprietary pricing models that the Company utilizes to make portfolio acquisition decisions. Accordingly, the Company's fair value estimates use Level 3 inputs as there is little observable market data available and management is required to use significant judgment in its estimates. Interest-bearing deposits: The carrying amount approximates fair value due to the short-term nature of the deposits and the observable quoted prices for similar instruments in active markets. Accordingly, the Company uses Level 2 inputs for its fair value estimates. Revolving lines of credit: The carrying amount approximates fair value due to the short-term nature of the interest rate periods and the observable quoted prices for similar instruments in active markets. Accordingly, the Company uses Level 2 inputs for its fair value estimate. Term loan: The carrying amount approximates fair value due to the short-term nature of the interest rate periods and the observable quoted prices for similar instruments in active markets. Accordingly, the Company uses Level 2 inputs for its fair value estimate. Senior notes and Convertible notes: The fair value estimates for the Senior notes and Convertible notes incorporate quoted market prices obtained from secondary market broker quotes, which were derived from a variety of inputs including client orders, information from their pricing vendors, modeling software and actual trading prices when they occur. Accordingly, the Company uses Level 2 inputs for its fair value estimates. Financial Instruments Carried at Fair Value The carrying amounts in the following tables were measured at fair value on a recurring basis in the Company's Consolidated Balance Sheets at September 30, 2023 and December 31, 2022 (amounts in thousands): Fair Value Measurements as of September 30, 2023 Level 1 Level 2 Level 3 Total Assets: Government securities $ 62,755 $ — $ — $ 62,755 Derivative contracts (recorded in Other assets) — 42,862 — 42,862 Liabilities: Derivative contracts (recorded in Other liabilities) — 3,401 — 3,401 Fair Value Measurements as of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Government securities $ 66,813 $ — $ — $ 66,813 Derivative contracts (recorded in Other assets) — 37,792 — 37,792 Liabilities: Derivative contracts (recorded in Other liabilities) — 19,120 — 19,120 Government securities: Fair value of the Company's investments in government securities is estimated using quoted market prices. Accordingly, the Company uses Level 1 inputs. Derivative contracts: Fair value of derivative contracts is estimated using industry standard valuation models. These models project future cash flows and discount the future amounts to a present value using market-based observable inputs, including interest rate curves and other factors. Accordingly, the Company uses Level 2 inputs for its fair value estimates. Investments Measured Using Net Asset Value ("NAV") Private equity funds: This class of investments consists of private equity funds that invest primarily in loans and securities, including single-family residential debt; corporate debt products; and financially-oriented, real-estate-rich and other operating companies in the Americas, Western Europe and Japan. These investments are subject to certain restrictions regarding transfers and withdrawals. The investments cannot be redeemed with the funds. Instead, the nature of the investments in this class is that distributions are received through the liquidation of the underlying assets of the fund. The investments are expected to be returned through distributions as a result of liquidation of the funds' un derlying assets over one to five years. The fair value of these private equity funds following the application of the NAV practical expedient was $2.9 million an d $4.4 million as of September 30, 2023 and December 31, 2022, respectively. Impairment of Real Estate During the three months ended September 30, 2023, the Company determined that it would cease call center operations at one of its owned regional offices in the U.S. As a result, the Company recorded a pre-tax impairment charge of $5.0 million on the associated building and improvements. The impairment was determined by comparing the fair value of the building and improvements to carrying value, as required under ASC Topic 360, "Property, Plant, and Equipment". Fair value was based on an appraisal performed by a third-party valuation specialist, which considered Level 2 inputs in the form of prices paid for comparable properties in the same market.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss: Reclassifications out of accumulated other comprehensive loss for the three and nine months ended September 30, 2023 and 2022, were as follows (amounts in thousands): Three Months Ended September 30, Gains/(losses) on cash flow hedges 2023 2022 Location in the Consolidated Income Statement Interest rate swaps $ 6,498 $ 383 Interest expense, net Income tax effect of item above (1,550) 10 Income tax expense/(benefit) Total gains on cash flow hedges $ 4,948 $ 393 Nine Months Ended September 30, Gains/(losses) on cash flow hedges 2023 2022 Location in the Consolidated Income Statement Interest rate swaps $ 18,666 $ (3,819) Interest expense, net Income tax effect of item above (4,464) 918 Income tax expense/(benefit) Total gains/(losses) on cash flow hedges $ 14,202 $ (2,901) The following tables represent the changes in accumulated other comprehensive loss by component, after tax, for the three and nine months ended September 30, 2023 and 2022 (amounts in thousands): Three Months Ended September 30, 2023 Debt Securities Cash Flow Currency Translation Accumulated Other Available-for-sale Hedges Adjustments Comprehensive Loss (1) Balance at beginning of period $ (189) $ 28,692 $ (376,503) $ (348,000) Other comprehensive loss before reclassifications (26) (2,712) (31,603) (34,341) Reclassifications, net — (4,948) — (4,948) Net current period other comprehensive loss (26) (7,660) (31,603) (39,289) Balance at end of period $ (215) $ 21,032 $ (408,106) $ (387,289) Three Months Ended September 30, 2022 Debt Securities Cash Flow Currency Translation Accumulated Other Available-for-sale Hedges Adjustments Comprehensive Loss (1) Balance at beginning of period $ (623) $ 19,046 $ (366,244) $ (347,821) Other comprehensive gain/(loss) before reclassifications 133 19,983 (97,988) (77,872) Reclassifications, net — (393) — (393) Net current period other comprehensive gain/(loss) 133 19,590 (97,988) (78,265) Balance at end of period $ (490) $ 38,636 $ (464,232) $ (426,086) (1) Net of deferred taxes for unre alized (gains)/losses from cash flow hedges of $2.5 million and $(3.5) million for the three months ended September 30, 2023 and 2022, respectively. Nine Months Ended September 30, 2023 Debt Securities Cash Flow Currency Translation Accumulated Other Available-for-sale Hedges Adjustments Comprehensive Loss (1) Balance at beginning of period $ (237) $ 27,804 $ (375,493) $ (347,926) Other comprehensive gain/(loss) before reclassifications 22 7,430 (32,613) (25,161) Reclassifications, net — (14,202) — (14,202) Net current period other comprehensive gain/(loss) 22 (6,772) (32,613) (39,363) Balance at end of period $ (215) $ 21,032 $ (408,106) $ (387,289) Nine Months Ended September 30, 2022 Debt Securities Cash Flow Currency Translation Accumulated Other Available-for-sale Hedges Adjustments Comprehensive Loss (1) Balance at beginning of period $ (221) $ (5,371) $ (261,317) $ (266,909) Other comprehensive gain/(loss) before reclassifications (269) 41,106 (202,915) (162,078) Reclassifications, net — 2,901 — 2,901 Net current period other comprehensive gain/(loss) (269) 44,007 (202,915) (159,177) Balance at end of period $ (490) $ 38,636 $ (464,232) $ (426,086) (1) Net of deferred taxes for unr ealized gains from cash flow hedges of $(7.0) million and $(6.1) million for the nine months ended September 30, 2023 and 2022, respectively.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Earnings Per Share	Earnings per Share: Basic EPS is computed by dividing net income available to common stockholders of PRA Group, Inc. by weighted average common shares outstanding. Diluted EPS is computed using the same components as basic EPS, with the denominator adjusted for the dilutive effect of the conversion spread of the Convertible Notes and nonvested share awards, if they are dilutive. There were no dilutive effects caused by the Convertible Notes since issuance through their retirement on June 1, 2023. Share-based awards that are contingent upon the attainment of performance goals are included in the computation of diluted EPS if the effect is dilutive. The dilutive effect of nonvested shares is computed using the treasury stock method, which assumes any proceeds that could be obtained upon the vesting of nonvested shares would be used to purchase common shares at the average market price for the period. On February 25, 2022, the Company's Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to $150.0 million of its common stock. A s of September 30, 2023, the Company had $67.7 million remaining for share repurchases, which is subject to restrictive covenants contained in our credit facilities and senior note indentures. Considering these covenants, we did not repurchase any common stock during the nine months ended September 30, 2023. The following table provides a reconciliation between the computation of basic E PS and diluted EPS for the three and nine months ended September 30, 2023 and 2022 (amounts in thousands, except per share amounts): Three Months Ended September 30, 2023 2022 Net Loss Attributable to PRA Group, Inc. Weighted EPS Net Income Attributable to PRA Group, Inc. Weighted EPS Basic EPS $ (12,262) 39,242 $ (0.31) $ 24,732 39,018 $ 0.63 Dilutive effect of nonvested share awards — — 152 — Diluted EPS $ (12,262) 39,242 $ (0.31) $ 24,732 39,170 $ 0.63 Nine Months Ended September 30, 2023 2022 Net Loss Attributable to PRA Group, Inc. Weighted EPS Net Income Attributable to PRA Group, Inc. Weighted EPS Basic EPS $ (74,695) 39,155 $ (1.91) $ 101,188 39,858 $ 2.54 Dilutive effect of nonvested share awards — — 267 (0.02) Diluted EPS $ (74,695) 39,155 $ (1.91) $ 101,188 40,125 $ 2.52 There were no options outstanding, antidilutive or otherwise, as of September 30, 2023 and 2022.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes: The Company accounts for income taxes in accordance with Financial Accounting Standards Board ("FASB") ASC Topic 740 "Income Taxes" ("ASC 740") as it relates to the provision for income taxes and uncertainty in income taxes. The guidance prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As of September 30, 2023, the tax years subject to examination by the major federal, state and international taxing jurisdictions ar e 2014 an d subsequent years. The Company intends for predominantly all international earnings to be indefinitely reinvested in its international operations; therefore, recording deferred tax liabilities for such unremitted earnings is not required. If international earnings were repatriated or deemed repatriated due to intercompany loans, the Company may need to accrue and pay taxes, although foreign tax credits and exemptions may be available to partially reduce or eliminate income and withholding taxes. Any deemed repatriations from additional intercompany loans would be expected to have little or no tax impact. The amount of cash on hand related to international operations with indefinitely reinvested earnings was $88.8 million and $75.3 million as of September 30, 2023 and December 31, 2022, respectively.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	Commitments and Contingencies: Employment Agreements: The Company has entered into employment agreements with certain of its current and former U.S. executive officers. Such agreements provide for base salary payments as well as potential discretionary bonuses that consider the Company’s overall performance against its short and long-term financial and strategic objectives. The agreements also contain customary confidentiality and non-compete provisions. As of September 30, 2023, estima ted future compensation under these agreements was $4.3 million. Outside the U.S., the Company has entered into employment agreements with certain employees pursuant to local country regulations. Generally, these agreements do not have expiration dates. As a result, it is impractical to estimate the amount of future compensation under these agreements. Accordingly, the future compensation under these agreements is not included in the $4.3 million to tal a bove. Forward Flow Agreements: The Company is party to several forward flow agreements for the purchase of nonperforming loans at pre-established prices. As of September 30, 2023, the maximum amount the Compa ny could be oblig ated to purchase under forward flow agreements was $538.0 million. This amount is based on sellers' estimates of future flow sales and is dependent on actual delivery compared to these estimates. Accordingly, amounts purchased under these agreements may vary and are often less than the maximum amounts. Finance Receivables: Certain agreements for the purchase of finance receivables portfolios contain provisions that may, in limited circumstances, require the Company to refund a portion or all of the collections subsequently received by the Company on particular accounts. The potential refunds as of the balance sheet date are not considered to be significant. Litigation and Regulatory Matters: The Company and its subsidiaries are from time to time subject to a variety of routine legal and regulatory claims, inquiries and proceedings and regulatory matters, most of which are incidental to the ordinary course of its business. The Company initiates lawsuits against customers and is occasionally countersued by them in such actions. Also, customers, either individually, as members of a class action, or through a governmental entity on behalf of customers, may initiate litigation against the Company in which they allege that the Company has violated a state or federal law in the process of collecting on an account. From time to time, other types of lawsuits are brought against the Company. Additionally, the Company receives subpoenas and other requests or demands for information from regulators or governmental authorities who are investigating the Company's debt collection activities. The Company accrues for potential liability arising from legal proceedings and regulatory matters when it is probable that such liability has been incurred and the amount of the loss can be reasonably estimated. This determination is based upon currently available information for those proceedings in which the Company is involved, taking into account the Company's best estimate of such losses for those cases for which such estimates can be made. The Company's estimate involves significant judgment given the varying stages of the proceedings (including the fact that many of them are currently in preliminary stages), the number of unresolved issues in many of the proceedings (including issues regarding class certification and the scope of many of the claims), and the related uncertainty of the potential outcomes of these proceedings. In making determinations of the likely outcome of pending litigation, the Company considers many factors, including, but not limited to, the nature of the claim, the Company's experience with similar types of claims, the jurisdiction in which the matter is filed, input from outside legal counsel, the likelihood of resolving the matter through alternative mechanisms, the matter's current status and the damages sought or demands made. Accordingly, the Company's estimate will change from time to time, and actual losses could be more than the current estimate. The Company believes that the estimate of the aggregate range of reasonably possible losses in excess of the amount accrued for its legal proceedings outstanding at September 30, 2023, where the range of loss can be estimated, was not material. In certain legal proceedings, the Company may have recourse to insurance or third-party contractual indemnities to cover all or portions of its litigation expenses, judgments, or settlements. Loss estimates and accruals for potential liability related to legal proceedings are typically exclusive of potential recoveries, if any, under the Company's insurance policies or third-party indemnities.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net income	$ (12,262)	$ 24,732	$ (74,695)	$ 101,188

Insider Trading Arrangements

Insider Trading Arrangements	9 Months Ended
	Sep. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Organization and Business (Poli

Organization and Business (Policies)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of presentation: The Consolidated Financial Statements of the Company are prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). The accompanying interim financial statements have been prepared in accordance with the instructions for Quarterly Reports on Form 10-Q and, therefore, do not include all information and Notes to the Consolidated Financial Statements necessary for a complete presentation of financial position, results of operations, comprehensive income/(loss) and cash flows in conformity with GAAP. In the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair presentation of the Company's Consolidated Balance Sheets as of September 30, 2023, its Consolidated Income Statements and Statements of Comprehensive Income for the three and nine months ended September 30, 2023 and 2022, and its Consolidated Statements of Changes in Equity and Statements of Cash Flows for the nine months ended September 30, 2023 and 2022, have been included. The Company's Consolidated Income Statements for the three and nine months ended September 30, 2023 may not be indicative of future results.
Consolidation	Consolidation : The Consolidated Financial Statements include the accounts of PRA Group and other entities in which the Company has a controlling interest. All significant intercompany accounts and transactions have been eliminated. Entities in which the Company has a controlling financial interest, through ownership of the majority of the entities’ voting equity interests, or through other contractual rights that give the Company control, consist of entities which purchase and collect on portfolios of nonperforming loans. Investments in companies in which the Company has significant influence over operating and financing decisions, but does not own a majority of the voting equity interests or exercise control, are accounted for in accordance with the equity method of accounting, which requires the Company to recognize its proportionate share of the entity's net earnings. Income or loss from these investments is included in Other revenue. The Company performs on-going reassessments of whether changes in facts and circumstances regarding the Company’s involvement with an entity would cause the Company’s consolidation conclusions to change.
Segments	Segments : The Company has determined that it has two operating segments that meet the aggregation criteria of Accounting Standards Codification ("ASC") 280, Segment Reporting ("ASC 280") and, therefore, it has one reportable segment; accounts receivable management. This conclusion is based on similarities among the operating units, including economic characteristics, the nature of the products and services, the nature of the production processes, the types or class of customer for their products and services, the methods used to distribute their products and services and the nature of the regulatory environment.
New Accounting Pronouncements	Recently issued accounting standards not yet adopted: The Company does not expect that any recently issued accounting pronouncements will have a material effect on its Consolidated Financial Statements.

Organization and Business (Tabl

Organization and Business (Tables)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Revenue And Long-Lived Assets Held By Geographical Location	Revenues and long-lived assets by geographical location: Revenues for the three and nine months ended September 30, 2023 and 2022, and long-lived assets held as of September 30, 2023 and 2022, both for the U.S., the Company's country of domicile, and outside of the U.S., were as follows (amounts in thousands): As of and for the As of and for the Three Months Ended September 30, 2023 Three Months Ended September 30, 2022 Revenues (2) Long-Lived Assets Revenues (2) Long-Lived Assets U.S. $ 105,456 $ 61,788 $ 138,398 $ 80,496 United Kingdom 30,978 11,233 37,032 10,762 Brazil 24,749 3 14,293 3 Other (1) 55,247 12,694 55,084 13,448 Total $ 216,430 $ 85,718 $ 244,807 $ 104,709 As of and for the As of and for the Nine Months Ended September 30, 2023 Nine Months Ended September 30, 2022 Revenues (2) Long-Lived Assets Revenues (2) Long-Lived Assets U.S. $ 258,848 $ 61,788 $ 426,675 $ 80,496 United Kingdom 99,547 11,233 126,866 10,762 Brazil 69,383 3 22,629 3 Other (1) 153,358 12,694 167,504 13,448 Total $ 581,136 $ 85,718 $ 743,674 $ 104,709 (1) None of the countries included in "Other" comprise greater than 10% of the Company's consolidated revenues or long-lived assets. (2) Based on the Company’s financial statement information used to produce the Company's general-purpose financial statements, it is impracticable to report further breakdowns of revenues from external customers by product or service.

Finance Receivables, net (Table

Finance Receivables, net (Tables)	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
Schedule of Finance Receivables, Net	Finance receivables, net consisted of the following at September 30, 2023 and December 31, 2022 (amounts in thousands): September 30, 2023 December 31, 2022 Amortized cost $ — $ — Negative allowance for expected recoveries 3,460,804 3,295,008 Balance at end of period $ 3,460,804 $ 3,295,008 Three Months Ended September 30, 2023 and 2022
Schedule of Changes in Negative Allowance for Expected Recoveries	Changes in the negative allowance for expected recoveries by portfolio segment for the three months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Three Months Ended September 30, 2023 Core Insolvency Total Balance at beginning of period $ 3,086,405 $ 338,143 $ 3,424,548 Initial negative allowance for expected recoveries - portfolio acquisitions (1) 248,181 63,002 311,183 Foreign currency translation adjustment (58,878) (6,786) (65,664) Recoveries applied to negative allowance (2) (189,710) (41,709) (231,419) Changes in expected recoveries (3) 15,894 6,262 22,156 Balance at end of period $ 3,101,892 $ 358,912 $ 3,460,804 Three Months Ended September 30, 2022 Core Insolvency Total Balance at beginning of period $ 2,814,761 $ 368,871 $ 3,183,632 Initial negative allowance for expected recoveries - portfolio acquisitions (1) 160,206 22,898 183,104 Foreign currency translation adjustment (133,263) (14,254) (147,517) Recoveries applied to negative allowance (2) (186,112) (44,083) (230,195) Changes in expected recoveries (3) 38,686 9,650 48,336 Balance at end of period $ 2,694,278 $ 343,082 $ 3,037,360 (1) Initial negative allowance for expected recoveries - portfolio acquisitions Portfolio acquisitions for the three months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Three Months Ended September 30, 2023 Core Insolvency Total Face value $ 1,992,448 $ 382,363 $ 2,374,811 Noncredit discount (209,131) (23,837) (232,968) Allowance for credit losses at acquisition (1,535,136) (295,524) (1,830,660) Purchase price $ 248,181 $ 63,002 $ 311,183 Three Months Ended September 30, 2022 Core Insolvency Total Face value $ 1,482,758 $ 123,369 $ 1,606,127 Noncredit discount (126,205) (7,874) (134,079) Allowance for credit losses at acquisition (1,196,347) (92,597) (1,288,944) Purchase price $ 160,206 $ 22,898 $ 183,104 The initial negative allowance recorded on portfolio acquisitions for the three months ended September 30, 2023 and 2022 was as follows (amounts in thousands): Three Months Ended September 30, 2023 Core Insolvency Total Allowance for credit losses at acquisition $ (1,535,136) $ (295,524) $ (1,830,660) Writeoffs, net 1,535,136 295,524 1,830,660 Expected recoveries 248,181 63,002 311,183 Initial negative allowance for expected recoveries $ 248,181 $ 63,002 $ 311,183 Three Months Ended September 30, 2022 Core Insolvency Total Allowance for credit losses at acquisition $ (1,196,347) $ (92,597) $ (1,288,944) Writeoffs, net 1,196,347 92,597 1,288,944 Expected recoveries 160,206 22,898 183,104 Initial negative allowance for expected recoveries $ 160,206 $ 22,898 $ 183,104 (2) Recoveries applied to negative allowance Recoveries applied to the negative allowance for the three months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Three Months Ended September 30, 2023 Core Insolvency Total Recoveries (a) $ 369,385 $ 51,994 $ 421,379 Less - amounts reclassified to portfolio income 179,675 10,285 189,960 Recoveries applied to negative allowance $ 189,710 $ 41,709 $ 231,419 Three Months Ended September 30, 2022 Core Insolvency Total Recoveries (a) $ 361,089 $ 54,959 $ 416,048 Less - amounts reclassified to portfolio income 174,977 10,876 185,853 Recoveries applied to negative allowance $ 186,112 $ 44,083 $ 230,195 (a) Recoveries include cash collections, buybacks and other cash-based adjustments. (3) Changes in expected recoveries Changes in expected recoveries for the three months ended September 30, 2023 and 2022 were as follows (amounts in thousands): Three Months Ended September 30, 2023 Core Insolvency Total Changes in expected future recoveries $ 4,234 $ (168) $ 4,066 Recoveries received in excess of forecast 11,660 6,430 18,090 Changes in expected recoveries $ 15,894 $ 6,262 $ 22,156 Three Months Ended September 30, 2022 Core Insolvency Total Changes in expected future recoveries $ 17,851 $ 2,361 $ 20,212 Recoveries received in excess of forecast 20,835 7,289 28,124 Changes in expected recoveries $ 38,686 $ 9,650 $ 48,336

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Summary of Investments	Investments consisted of the following at September 30, 2023 and December 31, 2022 (amounts in thousands): September 30, 2023 December 31, 2022 Debt securities Available-for-sale $ 62,755 $ 66,813 Equity securities Private equity funds 2,911 4,373 Equity method investments 9,063 8,762 Total investments $ 74,729 $ 79,948
Schedule of Amortized Cost and Estimated Fair Value in Debt Securities	The amortized cost and fair value of investments in debt securities at September 30, 2023 and December 31, 2022 was as follows (amounts in thousands): September 30, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized (Losses) Aggregate Fair Value Available-for-sale Government securities $ 62,969 $ 36 $ (250) $ 62,755 December 31, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized (Losses) Aggregate Fair Value Available-for-sale Government securities $ 67,049 $ 1 $ (237) $ 66,813

Goodwill (Tables)

Goodwill (Tables)	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in Goodwill	hanges in goodwill for the three and nine months ended September 30, 2023 and 2022, were as follows (amounts in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Balance at beginning of period $ 414,905 $ 437,032 $ 435,921 $ 480,263 Change in foreign currency translation adjustment (2,392) (32,558) (23,408) (75,789) Balance at end of period $ 412,513 $ 404,474 $ 412,513 $ 404,474

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Lease, Cost	The components of lease expense for the three and nine months ended September 30, 2023 and 2022, were as follows (amounts in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Operating lease expense $ 2,617 $ 2,775 $ 8,132 $ 9,095 Short-term lease expense 526 775 1,553 1,874 Sublease income (21) (118) (296) (348) Total lease expense $ 3,122 $ 3,432 $ 9,389 $ 10,621 Supplemental cash flow information and non-cash activity related to leases for the nine months ended September 30, 2023 and 2022 was as follows (amounts in thousands): Nine Months Ended September 30, 2023 2022 Cash paid for amounts included in the measurement of operating lease liabilities $ 8,806 $ 8,923 ROU assets obtained in exchange for operating lease obligations (1) 2,663 5,910 (1) Includes the impact of new leases as well as remeasurements and modifications to existing leases. Lease term and discount rate information related to operating leases was as follows: Nine Months Ended September 30, 2023 2022 Weighted-average remaining lease term (years) 7.1 8.2 Weighted-average discount rate 4.65 % 4.48 %
Lessee, Operating Lease, Liability, Maturity	Maturities of lease liabilities at September 30, 2023 were as follows for the following periods (amounts in thousands): Operating Leases For the three months ending December 31, 2023 $ 2,600 For the year ending December 31, 2024 9,879 For the year ending December 31, 2025 9,608 For the year ending December 31, 2026 8,490 For the year ending December 31, 2027 5,724 Thereafter 25,391 Total lease payments 61,692 Less: imputed interest (10,034) Total present value of lease liabilities $ 51,658

Borrowings (Tables)

Borrowings (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of Debt	The Company's borrowings consisted of the following as of September 30, 2023 and December 31, 2022 (amounts in thousands): September 30, 2023 December 31, 2022 Americas revolving credit (1) $ 382,351 $ 186,867 UK revolving credit 500,257 453,528 Europe revolving credit 473,873 419,856 Term loan 442,500 450,000 Senior notes 1,046,000 650,000 Convertible notes — 345,000 2,844,981 2,505,251 Less: Debt discount and issuance costs (12,756) (10,393) Total $ 2,832,225 $ 2,494,858 (1) Includes the North American revolving credit facility and an unsecured credit agreement with Banco de Occidente (the "Colombian Revolving Credit Facility"). As of September 30, 2023, no amounts were outstanding under the Colombian Revolving Credit Facility ($0.5 million was outstanding as of December 31, 2022).
Schedule of Maturities of Long-term Debt	The following principal payments are due on the Company's borrowings as of September 30, 2023 for the 12-month periods ending September 30, (amounts in thousands): 2024 $ 10,000 2025 308,000 2026 1,305,108 2027 — 2028 871,873 Thereafter 350,000 Total $ 2,844,981
Schedule of Debt Interest Expense	Interest expense on the 2023 Notes was recognized using an effective interest rate of 4.00%, and for the three and nine months ended September 30, 2023 and 2022, was as follows (amounts in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Interest expense - stated coupon rate $ — $ 3,019 $ 5,032 $ 9,057 Interest expense - amortization of debt issuance costs — 429 748 1,284 Total interest expense - convertible notes $ — $ 3,448 $ 5,780 $ 10,341

Derivatives (Tables)

Derivatives (Tables)	9 Months Ended
	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	The following table summarizes the fair value of derivative instruments as of September 30, 2023 and December 31, 2022 (amounts in thousands): September 30, 2023 December 31, 2022 Balance Sheet Location Fair Value Balance Sheet Location Fair Value Derivatives designated as hedging instruments: Interest rate contracts Other assets $ 32,482 Other assets $ 37,305 Interest rate contracts Other liabilities 3,195 Other liabilities — Derivatives not designated as hedging instruments: Foreign currency contracts Other assets 10,380 Other assets 487 Foreign currency contracts Other liabilities 206 Other liabilities 19,120
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location	The following tables summarize the effects of derivatives designated as cash flow hedging instruments on the Company's Consolidated Financial Statements for the three and nine months ended September 30, 2023 and 2022 (amounts in thousands): Gain/(loss) recognized in OCI, net of tax Three Months Ended September 30, Nine Months Ended September 30, Derivatives designated as cash flow hedging instruments 2023 2022 2023 2022 Interest rate contracts $ (2,712) $ 19,983 $ 7,430 $ 41,106 Gain/(loss) reclassified from OCI into income Three Months Ended September 30, Nine Months Ended September 30, Location of gain/(loss) reclassified from OCI into income 2023 2022 2023 2022 Interest expense, net $ 6,498 $ 383 $ 18,666 $ (3,819)
Schedule of derivative instruments not designated as hedging instruments	The following table summarizes the effects of derivatives not designated as hedging instruments on the Company's Consolidated Income Statements for the three and nine months ended September 30, 2023 and 2022 (amounts in thousands): Gain/(loss) recognized in income Three Months Ended September 30, Derivatives not designated as hedging instruments Location of gain/(loss) recognized in income 2023 2022 Foreign currency contracts Foreign exchange gain, net $ 8,137 $ 33,019 Foreign currency contracts Interest expense, net 204 313 Gain/(loss) recognized in income Nine Months Ended September 30, Derivatives not designated as hedging instruments Location of gain/(loss) recognized in income 2023 2022 Foreign currency contracts Foreign exchange gain/(loss), net $ (7,149) $ 72,371 Foreign currency contracts Interest expense, net 1,357 (638)

Fair Value Measurements and D_2

Fair Value Measurements and Disclosures (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of financial instruments not required to be carried at fair value	The carrying amounts in the table below were recorded in the Company's Consolidated Balance Sheets at September 30, 2023 and December 31, 2022 (amounts in thousands): September 30, 2023 December 31, 2022 Carrying Estimated Carrying Estimated Financial assets: Cash and cash equivalents $ 105,172 $ 105,172 $ 83,376 $ 83,376 Finance receivables, net 3,460,804 3,005,033 3,295,008 3,167,813 Financial liabilities: Interest-bearing deposits 100,505 100,505 112,992 112,992 Revolving lines of credit 1,356,481 1,356,481 1,060,251 1,060,251 Term loan 442,500 442,500 450,000 450,000 Senior notes 1,046,000 923,125 650,000 580,433 Convertible notes — — 345,000 341,926
Schedule of financial instruments required to be carried at fair value	The carrying amounts in the following tables were measured at fair value on a recurring basis in the Company's Consolidated Balance Sheets at September 30, 2023 and December 31, 2022 (amounts in thousands): Fair Value Measurements as of September 30, 2023 Level 1 Level 2 Level 3 Total Assets: Government securities $ 62,755 $ — $ — $ 62,755 Derivative contracts (recorded in Other assets) — 42,862 — 42,862 Liabilities: Derivative contracts (recorded in Other liabilities) — 3,401 — 3,401 Fair Value Measurements as of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Government securities $ 66,813 $ — $ — $ 66,813 Derivative contracts (recorded in Other assets) — 37,792 — 37,792 Liabilities: Derivative contracts (recorded in Other liabilities) — 19,120 — 19,120

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Reclassification out of Accumulated Other Comprehensive Income	Reclassifications out of accumulated other comprehensive loss for the three and nine months ended September 30, 2023 and 2022, were as follows (amounts in thousands): Three Months Ended September 30, Gains/(losses) on cash flow hedges 2023 2022 Location in the Consolidated Income Statement Interest rate swaps $ 6,498 $ 383 Interest expense, net Income tax effect of item above (1,550) 10 Income tax expense/(benefit) Total gains on cash flow hedges $ 4,948 $ 393 Nine Months Ended September 30, Gains/(losses) on cash flow hedges 2023 2022 Location in the Consolidated Income Statement Interest rate swaps $ 18,666 $ (3,819) Interest expense, net Income tax effect of item above (4,464) 918 Income tax expense/(benefit) Total gains/(losses) on cash flow hedges $ 14,202 $ (2,901)
Schedule of Accumulated Other Comprehensive Income (Loss)	The following tables represent the changes in accumulated other comprehensive loss by component, after tax, for the three and nine months ended September 30, 2023 and 2022 (amounts in thousands): Three Months Ended September 30, 2023 Debt Securities Cash Flow Currency Translation Accumulated Other Available-for-sale Hedges Adjustments Comprehensive Loss (1) Balance at beginning of period $ (189) $ 28,692 $ (376,503) $ (348,000) Other comprehensive loss before reclassifications (26) (2,712) (31,603) (34,341) Reclassifications, net — (4,948) — (4,948) Net current period other comprehensive loss (26) (7,660) (31,603) (39,289) Balance at end of period $ (215) $ 21,032 $ (408,106) $ (387,289) Three Months Ended September 30, 2022 Debt Securities Cash Flow Currency Translation Accumulated Other Available-for-sale Hedges Adjustments Comprehensive Loss (1) Balance at beginning of period $ (623) $ 19,046 $ (366,244) $ (347,821) Other comprehensive gain/(loss) before reclassifications 133 19,983 (97,988) (77,872) Reclassifications, net — (393) — (393) Net current period other comprehensive gain/(loss) 133 19,590 (97,988) (78,265) Balance at end of period $ (490) $ 38,636 $ (464,232) $ (426,086) (1) Net of deferred taxes for unre alized (gains)/losses from cash flow hedges of $2.5 million and $(3.5) million for the three months ended September 30, 2023 and 2022, respectively. Nine Months Ended September 30, 2023 Debt Securities Cash Flow Currency Translation Accumulated Other Available-for-sale Hedges Adjustments Comprehensive Loss (1) Balance at beginning of period $ (237) $ 27,804 $ (375,493) $ (347,926) Other comprehensive gain/(loss) before reclassifications 22 7,430 (32,613) (25,161) Reclassifications, net — (14,202) — (14,202) Net current period other comprehensive gain/(loss) 22 (6,772) (32,613) (39,363) Balance at end of period $ (215) $ 21,032 $ (408,106) $ (387,289) Nine Months Ended September 30, 2022 Debt Securities Cash Flow Currency Translation Accumulated Other Available-for-sale Hedges Adjustments Comprehensive Loss (1) Balance at beginning of period $ (221) $ (5,371) $ (261,317) $ (266,909) Other comprehensive gain/(loss) before reclassifications (269) 41,106 (202,915) (162,078) Reclassifications, net — 2,901 — 2,901 Net current period other comprehensive gain/(loss) (269) 44,007 (202,915) (159,177) Balance at end of period $ (490) $ 38,636 $ (464,232) $ (426,086) (1) Net of deferred taxes for unr ealized gains from cash flow hedges of $(7.0) million and $(6.1) million for the nine months ended September 30, 2023 and 2022, respectively.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Reconciliation Between the Computation of Basic and Diluted EPS	The following table provides a reconciliation between the computation of basic E PS and diluted EPS for the three and nine months ended September 30, 2023 and 2022 (amounts in thousands, except per share amounts): Three Months Ended September 30, 2023 2022 Net Loss Attributable to PRA Group, Inc. Weighted EPS Net Income Attributable to PRA Group, Inc. Weighted EPS Basic EPS $ (12,262) 39,242 $ (0.31) $ 24,732 39,018 $ 0.63 Dilutive effect of nonvested share awards — — 152 — Diluted EPS $ (12,262) 39,242 $ (0.31) $ 24,732 39,170 $ 0.63 Nine Months Ended September 30, 2023 2022 Net Loss Attributable to PRA Group, Inc. Weighted EPS Net Income Attributable to PRA Group, Inc. Weighted EPS Basic EPS $ (74,695) 39,155 $ (1.91) $ 101,188 39,858 $ 2.54 Dilutive effect of nonvested share awards — — 267 (0.02) Diluted EPS $ (74,695) 39,155 $ (1.91) $ 101,188 40,125 $ 2.52

Organization and Business (Deta

Organization and Business (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) segment	Sep. 30, 2022 USD ($)	May 26, 2017 USD ($)
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of reportable segments | segment			1
Revenues	$ 216,430,000	$ 244,807,000	$ 581,136,000	$ 743,674,000
Long-Lived Assets	85,718,000	104,709,000	85,718,000	104,709,000
Note Due 2023 | Convertible Senior Notes
Revenues from External Customers and Long-Lived Assets [Line Items]
Principal amount					$ 345,000,000
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	105,456,000	138,398,000	258,848,000	426,675,000
Long-Lived Assets	61,788,000	80,496,000	61,788,000	80,496,000
UNITED KINGDOM
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	30,978,000	37,032,000	99,547,000	126,866,000
Long-Lived Assets	11,233,000	10,762,000	11,233,000	10,762,000
Outside the United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	55,247,000	55,084,000	153,358,000	167,504,000
Long-Lived Assets	12,694,000	13,448,000	12,694,000	13,448,000
BRAZIL
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	24,749,000	14,293,000	69,383,000	22,629,000
Long-Lived Assets	$ 3,000	$ 3,000	$ 3,000	$ 3,000

Finance Receivables, net (Rollf

Finance Receivables, net (Rollforward) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Receivables [Abstract]
Amortized cost	$ 0		$ 0			$ 0
Negative allowance for expected recoveries	3,460,804		3,460,804			3,295,008
Balance at end of period	3,460,804	$ 3,037,360	3,460,804	$ 3,037,360	$ 3,424,548	3,295,008	$ 3,183,632	$ 3,428,285
Financing Receivable, Allowance for Credit Losses [Line Items]
Balance at end of period	3,460,804	3,037,360	3,460,804	3,037,360	3,424,548	3,295,008	3,183,632	3,428,285
Initial negative allowance for expected recoveries - acquisitions	311,183	183,104	869,167	561,901
Foreign currency translation adjustment	(65,664)	(147,517)	(14,366)	(321,911)
Financing Receivable, Allowance for Credit Loss, Recovery	(231,419)	(230,195)	(695,385)	(765,732)
Changes in estimated recoveries	22,156	48,336	6,380	134,817
Core
Receivables [Abstract]
Balance at end of period	3,101,892	2,694,278	3,101,892	2,694,278	3,086,405	2,936,207	2,814,761	2,989,932
Financing Receivable, Allowance for Credit Losses [Line Items]
Balance at end of period	3,101,892	2,694,278	3,101,892	2,694,278	3,086,405	2,936,207	2,814,761	2,989,932
Initial negative allowance for expected recoveries - acquisitions	248,181	160,206	763,776	513,385
Foreign currency translation adjustment	(58,878)	(133,263)	(15,662)	(287,901)
Financing Receivable, Allowance for Credit Loss, Recovery	(189,710)	(186,112)	(574,993)	(628,293)
Changes in estimated recoveries	15,894	38,686	(7,436)	107,155
Insolvency
Receivables [Abstract]
Balance at end of period	358,912	343,082	358,912	343,082	338,143	358,801	368,871	438,353
Financing Receivable, Allowance for Credit Losses [Line Items]
Balance at end of period	358,912	343,082	358,912	343,082	$ 338,143	$ 358,801	$ 368,871	$ 438,353
Initial negative allowance for expected recoveries - acquisitions	63,002	22,898	105,391	48,516
Foreign currency translation adjustment	(6,786)	(14,254)	1,296	(34,010)
Financing Receivable, Allowance for Credit Loss, Recovery	(41,709)	(44,083)	(120,392)	(137,439)
Changes in estimated recoveries	$ 6,262	$ 9,650	$ 13,816	$ 27,662

Finance Receivables, net Financ

Finance Receivables, net Finance Receivables, net (Allowance for Expected Recoveries) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Balance at beginning of period			$ 3,295,008
Initial negative allowance for expected recoveries - acquisitions	$ 311,183	$ 183,104	869,167	$ 561,901
Foreign currency translation adjustment	(65,664)	(147,517)	(14,366)	(321,911)
Recoveries applied to negative allowance	(231,419)	(230,195)	(695,385)	(765,732)
Changes in estimated recoveries	22,156	48,336	6,380	134,817
Balance at end of period	3,460,804		3,460,804
Balance at end of period	3,460,804	3,037,360	3,460,804	3,037,360	$ 3,424,548	$ 3,295,008	$ 3,183,632	$ 3,428,285
Core
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Initial negative allowance for expected recoveries - acquisitions	248,181	160,206	763,776	513,385
Foreign currency translation adjustment	(58,878)	(133,263)	(15,662)	(287,901)
Recoveries applied to negative allowance	(189,710)	(186,112)	(574,993)	(628,293)
Changes in estimated recoveries	15,894	38,686	(7,436)	107,155
Balance at end of period	3,101,892	2,694,278	3,101,892	2,694,278	3,086,405	2,936,207	2,814,761	2,989,932
Insolvency
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Initial negative allowance for expected recoveries - acquisitions	63,002	22,898	105,391	48,516
Foreign currency translation adjustment	(6,786)	(14,254)	1,296	(34,010)
Recoveries applied to negative allowance	(41,709)	(44,083)	(120,392)	(137,439)
Changes in estimated recoveries	6,262	9,650	13,816	27,662
Balance at end of period	$ 358,912	$ 343,082	$ 358,912	$ 343,082	$ 338,143	$ 358,801	$ 368,871	$ 438,353

Finance Receivables, net (Portf

Finance Receivables, net (Portfolio Acquisitions) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Face value	$ 2,374,811	$ 1,606,127	$ 6,296,787	$ 3,796,233
Noncredit discount	(232,968)	(134,079)	(638,795)	(380,114)
Allowance for credit losses at acquisition	(1,830,660)	(1,288,944)	(4,788,825)	(2,854,218)
Purchase price	311,183	183,104	869,167	561,901
Core
Accounts, Notes, Loans and Financing Receivable [Line Items]
Face value	1,992,448	1,482,758	5,717,674	3,539,705
Noncredit discount	(209,131)	(126,205)	(600,174)	(363,138)
Allowance for credit losses at acquisition	(1,535,136)	(1,196,347)	(4,353,724)	(2,663,182)
Purchase price	248,181	160,206	763,776	513,385
Insolvency
Accounts, Notes, Loans and Financing Receivable [Line Items]
Face value	382,363	123,369	579,113	256,528
Noncredit discount	(23,837)	(7,874)	(38,621)	(16,976)
Allowance for credit losses at acquisition	(295,524)	(92,597)	(435,101)	(191,036)
Purchase price	$ 63,002	$ 22,898	$ 105,391	$ 48,516

Finance Receivables, net Fina_2

Finance Receivables, net Finance Receivables, net (Initial Negative Allowance for Recoveries) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for credit losses at acquisition	$ (1,830,660)	$ (1,288,944)	$ (4,788,825)	$ (2,854,218)
Writeoffs, net	1,830,660	1,288,944	4,788,825	2,854,218
Expected recoveries	311,183	183,104	869,167	561,901
Purchase price	311,183	183,104	869,167	561,901
Amortized cost	0		0			$ 0
Negative allowance for expected recoveries	3,460,804		3,460,804			3,295,008
Balance at end of period	3,460,804	3,037,360	3,460,804	3,037,360	$ 3,424,548	3,295,008	$ 3,183,632	$ 3,428,285
Core
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for credit losses at acquisition	(1,535,136)	(1,196,347)	(4,353,724)	(2,663,182)
Writeoffs, net	1,535,136	1,196,347	4,353,724	2,663,182
Expected recoveries	248,181	160,206	763,776	513,385
Purchase price	248,181	160,206	763,776	513,385
Balance at end of period	3,101,892	2,694,278	3,101,892	2,694,278	3,086,405	2,936,207	2,814,761	2,989,932
Insolvency
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for credit losses at acquisition	(295,524)	(92,597)	(435,101)	(191,036)
Writeoffs, net	295,524	92,597	435,101	191,036
Expected recoveries	63,002	22,898	105,391	48,516
Purchase price	63,002	22,898	105,391	48,516
Balance at end of period	$ 358,912	$ 343,082	$ 358,912	$ 343,082	$ 338,143	$ 358,801	$ 368,871	$ 438,353

Finance Receivables, net Fina_3

Finance Receivables, net Finance Receivables, net (Recoveries) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Financing Receivable, Allowance for Credit Losses [Line Items]
Recoveries	$ 421,379	$ 416,048	$ 1,257,877	$ 1,353,126
Less - amounts reclassified to portfolio income	189,960	185,853	562,492	587,394
Recoveries applied to negative allowance	231,419	230,195	695,385	765,732
Core
Financing Receivable, Allowance for Credit Losses [Line Items]
Recoveries	369,385	361,089	1,106,799	1,179,746
Less - amounts reclassified to portfolio income	179,675	174,977	531,806	551,453
Recoveries applied to negative allowance	189,710	186,112	574,993	628,293
Insolvency
Financing Receivable, Allowance for Credit Losses [Line Items]
Recoveries	51,994	54,959	151,078	173,380
Less - amounts reclassified to portfolio income	10,285	10,876	30,686	35,941
Recoveries applied to negative allowance	$ 41,709	$ 44,083	$ 120,392	$ 137,439

Finance Receivables, net (Chang

Finance Receivables, net (Changes in Estimated Future Recoveries) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Financing Receivable, Allowance for Credit Losses [Line Items]
Changes in expected future recoveries	$ 4,066	$ 20,212	$ (40,896)	$ 47,156
Recoveries received in excess of forecast	18,090	28,124	47,276	87,661
Financing Receivable, Allowance For Credit Loss, Changes In Estimated Recoveries	22,156	48,336	6,380	134,817
Recoveries	421,379	416,048	1,257,877	1,353,126
Less - amounts reclassified to portfolio income	189,960	185,853	562,492	587,394
Recoveries applied to negative allowance	231,419	230,195	695,385	765,732
Core
Financing Receivable, Allowance for Credit Losses [Line Items]
Changes in expected future recoveries	4,234	17,851	(40,919)	43,262
Recoveries received in excess of forecast	11,660	20,835	33,483	63,893
Financing Receivable, Allowance For Credit Loss, Changes In Estimated Recoveries	15,894	38,686	(7,436)	107,155
Recoveries	369,385	361,089	1,106,799	1,179,746
Less - amounts reclassified to portfolio income	179,675	174,977	531,806	551,453
Recoveries applied to negative allowance	189,710	186,112	574,993	628,293
Insolvency
Financing Receivable, Allowance for Credit Losses [Line Items]
Changes in expected future recoveries	(168)	2,361	23	3,894
Recoveries received in excess of forecast	6,430	7,289	13,793	23,768
Financing Receivable, Allowance For Credit Loss, Changes In Estimated Recoveries	6,262	9,650	13,816	27,662
Recoveries	51,994	54,959	151,078	173,380
Less - amounts reclassified to portfolio income	10,285	10,876	30,686	35,941
Recoveries applied to negative allowance	$ 41,709	$ 44,083	$ 120,392	$ 137,439

Finance Receivables, net (Narra

Finance Receivables, net (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Financing Receivable, Allowance for Credit Losses [Line Items]
Changes in estimated recoveries	$ 22,156	$ 48,336		$ 6,380	$ 134,817
Recoveries received in excess of forecast	18,090	28,124		47,276	87,661
Changes in expected future recoveries	$ 4,066	$ 20,212		$ (40,896)	$ 47,156
Write down			$ 20,500

Investments - Summary of Invest

Investments - Summary of Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt securities
Debt Securities, Available-for-Sale	$ 62,755	$ 66,813
Equity Securities [Abstract]
Equity Method Investments	9,063	8,762
Investments	74,729	79,948
Private equity funds
Equity Securities [Abstract]
Equity Securities, FV-NI, Current	$ 2,911	$ 4,373

Investments - Amortized Costs (

Investments - Amortized Costs (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Available-for-sale
Debt Securities, Available-for-Sale	$ 62,755	$ 66,813
Government Bonds and Fixed Income Funds
Available-for-sale
Debt Securities, Available-for-Sale, Amortized Cost	62,969	67,049
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	36	1
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	(250)	(237)
Debt Securities, Available-for-Sale	$ 62,755	$ 66,813

Investments - Narrative (Detail

Investments - Narrative (Details) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)
Debt and Equity Securities, FV-NI [Line Items]
Cost-method investment, ownership percentage	1%
Government Bonds and Fixed Income Funds [Member]
Debt and Equity Securities, FV-NI [Line Items]
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five	$ 3.9
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	$ 58.8
RCB Investimentos S.A. (RCB) | RCB Investimentos S.A.
Debt and Equity Securities, FV-NI [Line Items]
Ownership percentage	11.70%

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 414,905	$ 437,032	$ 435,921	$ 480,263
Goodwill, Foreign Currency Translation Gain (Loss)	(2,392)	(32,558)	(23,408)	(75,789)
Goodwill, Ending Balance	$ 412,513	$ 404,474	$ 412,513	$ 404,474

Leases - Narrative (Details)

Leases - Narrative (Details)	9 Months Ended
	Sep. 30, 2023
Lessee, Lease, Description [Line Items]
Renewal term	5 years
Termination period	1 year
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term	11 years

Leases - Lease Cost and Other I

Leases - Lease Cost and Other Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Operating Lease, Cost	$ 2,617	$ 2,775	$ 8,132	$ 9,095
Short-Term Lease, Cost	526	775	1,553	1,874
Sublease Income	(21)	(118)	(296)	(348)
Lease, Cost, Total	$ 3,122	$ 3,432	9,389	10,621
Operating Lease, Payments			8,806	8,923
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability			$ 2,663	$ 5,910
Operating Lease, Weighted Average Remaining Lease Term	7 years 1 month 6 days	8 years 2 months 12 days	7 years 1 month 6 days	8 years 2 months 12 days
Operating Lease, Weighted Average Discount Rate, Percent	4.65%	4.48%	4.65%	4.48%

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Liability Maturity (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year	$ 2,600
Lessee, Operating Lease, Liability, to be Paid, Year One	9,879
Lessee, Operating Lease, Liability, to be Paid, Year Two	9,608
Lessee, Operating Lease, Liability, to be Paid, Year Three	8,490
Lessee, Operating Lease, Liability, to be Paid, Year Four	5,724
Lessee, Operating Lease, Liability, To Be Paid, After Year Four	25,391
Lessee, Operating Lease, Liability, to be Paid, Total	61,692
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	(10,034)
Operating Lease, Liability	$ 51,658	$ 59,384

Borrowings - Components of Borr

Borrowings - Components of Borrowings (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Debt Instrument [Line Items]
Debt outstanding	$ 2,844,981		$ 2,844,981		$ 2,505,251
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	(12,756)		(12,756)		(10,393)
Debt, Long-Term and Short-Term, Combined Amount	2,832,225		2,832,225		2,494,858
Operating Income (Loss)	(43,046)	$ (70,788)	(54,963)	$ (226,492)
Term Loan
Debt Instrument [Line Items]
Debt outstanding	442,500		442,500		450,000
Senior Notes
Debt Instrument [Line Items]
Debt outstanding	1,046,000		1,046,000		650,000
Convertible Senior Notes
Debt Instrument [Line Items]
Debt outstanding	0		0		345,000
Americas Revolving Credit Facility | Line of Credit
Debt Instrument [Line Items]
Debt outstanding	382,351		382,351		186,867
UK revolving credit | Line of Credit
Debt Instrument [Line Items]
Debt outstanding	500,257		500,257		453,528
Europe revolving credit | Line of Credit
Debt Instrument [Line Items]
Debt outstanding	$ 473,873		$ 473,873		$ 419,856

Borrowings - Long-Term Debt Mat

Borrowings - Long-Term Debt Maturities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt, Maturity, Year One	$ 10,000
Long-Term Debt, Maturity, Year Two	308,000
Long-Term Debt, Maturity, Year Three	1,305,108
Long-Term Debt, Maturity, Year Four	0
Long-Term Debt, Maturity, Year Five	871,873
Thereafter	350,000
Total	$ 2,844,981	$ 2,505,251

Borrowings - North American Rev

Borrowings - North American Revolving Credit and Term Loan (Details)	3 Months Ended	9 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2023 USD ($)
Debt Instrument [Line Items]
Repurchase of senior notes	$ 4,000,000
Credit Agreement
Debt Instrument [Line Items]
Credit agreement consolidated leverage ratio	3.50	3.50
Consolidated senior secured leverage ratio	2.25	2.25
Maximum cash dividends	$ 20,000,000
Credit Agreement | Minimum
Debt Instrument [Line Items]
Unused commitment fee		0.30%
Credit Agreement | Maximum
Debt Instrument [Line Items]
Unused commitment fee		0.35%
North American Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity	1,500,000,000	$ 1,500,000,000
Unused portion	692,600,000	692,600,000
Current borrowing capacity	70,300,000	70,300,000
Additional borrowing capacity	622,300,000	622,300,000
UK Credit Agreement
Debt Instrument [Line Items]
Unused portion	299,700,000	299,700,000
Current borrowing capacity	57,400,000	57,400,000
Additional borrowing capacity	$ 242,300,000	$ 242,300,000
Credit agreement consolidated leverage ratio	3.50	3.50
Consolidated senior secured leverage ratio	2.25	2.25
Convertible Senior Notes | Credit Agreement
Debt Instrument [Line Items]
Consolidated senior secured leverage ratio	1.60	1.60
Eurodollar Rate | Credit Agreement | Minimum
Debt Instrument [Line Items]
Basis spread variable rate		2%
Eurodollar Rate | Credit Agreement | Maximum
Debt Instrument [Line Items]
Basis spread variable rate		2.25%
Eurodollar Rate | UK Credit Agreement | Maximum
Debt Instrument [Line Items]
Basis spread variable rate		2.50%
Interest Rate Floor
Debt Instrument [Line Items]
Basis spread variable rate		0%
Line of Credit | Line of Credit
Debt Instrument [Line Items]
Long-term debt	$ 442,500,000	$ 442,500,000
Revolving Credit Facility | North American Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity	1,000,000,000	1,000,000,000
Line of credit facility, optional increase in borrowing capacity	500,000,000	500,000,000
Line of credit facility, option for letters of credit	25,000,000	25,000,000
Line of credit facility, option to reduce borrowing capacity	25,000,000	25,000,000
Revolving Credit Facility | Line of Credit | UK Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity	800,000,000	800,000,000
Line of credit facility, optional increase in borrowing capacity	$ 200,000,000	$ 200,000,000
Revolving Credit Facility | Line of Credit | UK Credit Agreement | Minimum
Debt Instrument [Line Items]
Unused commitment fee		0.30%
Consolidated senior secured leverage ratio	1.60	1.60
Revolving Credit Facility | Line of Credit | UK Credit Agreement | Maximum
Debt Instrument [Line Items]
Basis spread variable rate		2.75%
Unused commitment fee		0.35%
Canadian Revolving Credit Facility | North American Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 75,000,000	$ 75,000,000
Eligible Core Asset Pool | Credit Agreement
Debt Instrument [Line Items]
Percentage of maximum level of borrowings of ERC of eligible asset pools	35%
Eligible Core Asset Pool | UK Credit Agreement
Debt Instrument [Line Items]
Percentage of maximum level of borrowings of ERC of eligible asset pools	35%
Eligible Insolvent Asset Pool | Credit Agreement
Debt Instrument [Line Items]
Percentage of maximum level of borrowings of ERC of insolvent asset pools	55%
Eligible Insolvent Asset Pool | UK Credit Agreement
Debt Instrument [Line Items]
Percentage of maximum level of borrowings of ERC of insolvent asset pools	55%

Borrowings - European Revolving

Borrowings - European Revolving Credit Facility and Term Loan (Details) $ in Thousands, € in Millions, kr in Billions	9 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2023 EUR (€)	Sep. 30, 2023 SEK (kr)	Dec. 31, 2022 USD ($)
Line of Credit Facility [Line Items]
Debt outstanding	$ 2,844,981			$ 2,505,251
European Revolving Credit Facility | Revolving Credit Facility
Line of Credit Facility [Line Items]
Unused portion	337,900
Additional borrowing capacity	$ 187,800
Loan-to-value covenant	45%
Debt Instrument, covenant, interest bearing deposits, maximum | kr			kr 1.2
Credit agreement consolidated leverage ratio	3.50	3.50	3.50
Consolidated senior secured leverage ratio	2.25	2.25	2.25
European Revolving Credit Facility | Overdraft Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 40,000
Facility line fee	0.125%
Line of Credit | Europe revolving credit
Line of Credit Facility [Line Items]
Debt outstanding	$ 473,873			$ 419,856
Line of Credit | European Revolving Credit Facility | Revolving Credit Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity | €		€ 730
Long Term Line of Debt, Accordion Feature | €		€ 500
Unused commitment fee	1.085%
Unused line fee as a percentage of margin	35%
Current borrowing capacity	$ 150,100
Line of Credit Facility, Unused Capacity, Floor	0	0	0
Minimum | Interbank Offered Rate (IBOR) | Line of Credit | European Revolving Credit Facility | Revolving Credit Facility
Line of Credit Facility [Line Items]
Basis spread variable rate	2.80%
Maximum | Interbank Offered Rate (IBOR) | Line of Credit | European Revolving Credit Facility | Revolving Credit Facility
Line of Credit Facility [Line Items]
Basis spread variable rate	3.80%

Borrowings - Colombian Revolvin

Borrowings - Colombian Revolving Credit Facility (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Revolving Credit Facility | Colombian Revolving Credit Facility
Debt Instrument [Line Items]
Outstanding borrowings under credit facility	$ 0	$ 500,000

Borrowings - Convertible Senior

Borrowings - Convertible Senior Notes (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022	May 26, 2017
Debt Instrument [Line Items]
Debt outstanding	$ 2,844,981,000	$ 2,505,251,000
Convertible Senior Notes
Debt Instrument [Line Items]
Debt outstanding	$ 0	$ 345,000,000
Note Due 2023 | Convertible Senior Notes
Debt Instrument [Line Items]
Face amount			$ 345,000,000
Stated percentage			3.50%
Interest rate at period end	4%

Borrowings - Senior Notes (Deta

Borrowings - Senior Notes (Details) - USD ($)	Feb. 06, 2023	Sep. 22, 2021	Aug. 27, 2020	Sep. 30, 2023	May 26, 2017
2028 Notes
Line of Credit Facility [Line Items]
Debt Instrument, Repurchase Amount				$ 2,000,000
2028 Notes | Senior Notes
Line of Credit Facility [Line Items]
Face amount	$ 400,000,000
Stated percentage	8.375%
2028 Notes | Senior Notes | On Or After September 1, 2022
Line of Credit Facility [Line Items]
Redemption price of original principal amount	104.188%
2028 Notes | Senior Notes | February 1, 2023 To January 31, 2024
Line of Credit Facility [Line Items]
Redemption price of original principal amount	102.094%
2028 Notes | Senior Notes | On Or Before February 1, 2025
Line of Credit Facility [Line Items]
Redemption price, percentage of aggregate principal amount	40%
Redemption price of original principal amount	108.375%
Redemption price, minimum percentage of principal amount outstanding	60%
2028 Notes | Senior Notes | On Or Before February 1, 2025 | Change Of Control Event
Line of Credit Facility [Line Items]
Redemption price of original principal amount	101%
2028 Notes | Senior Notes | February 1, 2025 And Thereafter
Line of Credit Facility [Line Items]
Redemption price of original principal amount	100%
2025 Notes
Line of Credit Facility [Line Items]
Debt Instrument, Repurchase Amount				$ 2,000,000
2025 Notes | Senior Notes
Line of Credit Facility [Line Items]
Face amount			$ 300,000,000
Stated percentage			7.375%
2025 Notes | Senior Notes | On Or After September 1, 2022
Line of Credit Facility [Line Items]
Redemption price of original principal amount			103.688%
2025 Notes | Senior Notes | September 1, 2023 To October 31, 2024
Line of Credit Facility [Line Items]
Redemption price of original principal amount			101.844%
2025 Notes | Senior Notes | September 1, 2024 And Thereafter
Line of Credit Facility [Line Items]
Redemption price of original principal amount			100%
2025 Notes | Senior Notes | On Or Before September 1, 2022 | Change Of Control Event
Line of Credit Facility [Line Items]
Redemption price of original principal amount			101%
2029 Notes | Senior Notes
Line of Credit Facility [Line Items]
Face amount		$ 350,000,000
Stated percentage		5%
2029 Notes | Senior Notes | On Or After September 1, 2022
Line of Credit Facility [Line Items]
Redemption price of original principal amount		102.50%
2029 Notes | Senior Notes | September 1, 2023 To October 31, 2024
Line of Credit Facility [Line Items]
Redemption price of original principal amount		101.25%
2029 Notes | Senior Notes | September 1, 2024 And Thereafter
Line of Credit Facility [Line Items]
Redemption price of original principal amount		100%
2029 Notes | Senior Notes | On Or Before September 1, 2022
Line of Credit Facility [Line Items]
Redemption price, percentage of aggregate principal amount		40%
Redemption price of original principal amount		105%
Debt redemption period		90 days
Redemption price, minimum percentage of principal amount outstanding		60%
2029 Notes | Senior Notes | On Or Before September 1, 2022 | Change Of Control Event
Line of Credit Facility [Line Items]
Redemption price of original principal amount		101%
Note Due 2023 | Convertible Senior Notes
Line of Credit Facility [Line Items]
Face amount					$ 345,000,000
Stated percentage					3.50%

Borrowings - Interest Expense (

Borrowings - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	May 26, 2017
Debt Instrument [Line Items]
Amortization of Debt Issuance Costs	$ 0	$ 429	$ 748	$ 1,284
Convertible Senior Notes
Debt Instrument [Line Items]
Interest expense - stated coupon rate	0	3,019	5,032	9,057
Total interest expense - convertible notes	$ 0	$ 3,448	$ 5,780	$ 10,341
Convertible Senior Notes | Note Due 2023
Debt Instrument [Line Items]
Stated percentage					3.50%

Borrowings - UK Revolving Credi

Borrowings - UK Revolving Credit Facility (Details) - UK Credit Agreement	3 Months Ended	9 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2023 USD ($)
Line of Credit Facility [Line Items]
Consolidated senior secured leverage ratio	2.25	2.25
Unused portion	$ 299,700,000	$ 299,700,000
Current borrowing capacity	57,400,000	57,400,000
Additional borrowing capacity	$ 242,300,000	$ 242,300,000
Credit agreement consolidated leverage ratio	3.50	3.50
Eligible Core Asset Pool
Line of Credit Facility [Line Items]
Percentage of maximum level of borrowings of ERC of eligible asset pools	35%
Eligible Insolvent Asset Pool
Line of Credit Facility [Line Items]
Percentage of maximum level of borrowings of ERC of insolvent asset pools	55%
Maximum | Eurodollar Rate
Line of Credit Facility [Line Items]
Basis spread variable rate		2.50%
Debt Instrument, Basis Spread on Variable Rate, Credit Adjustment Spread		0.10%
Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 800,000,000	$ 800,000,000
Line of credit facility, optional increase in borrowing capacity	$ 200,000,000	$ 200,000,000
Revolving Credit Facility | Line of Credit | Maximum
Line of Credit Facility [Line Items]
Basis spread variable rate		2.75%
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage		0.35%
Revolving Credit Facility | Line of Credit | Minimum
Line of Credit Facility [Line Items]
Consolidated senior secured leverage ratio	1.60	1.60
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage		0.30%

Derivatives - Schedule of Deriv

Derivatives - Schedule of Derivatives by Balance Sheet Location (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Derivatives, Fair Value [Line Items]
Derivative Liability	$ 3,401	$ 19,120
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets	Other Assets
Derivative Asset	$ 42,862	$ 37,792
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Current	Other Liabilities, Current
Interest rate contracts | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative Liability	$ 3,195	$ 0
Derivative Asset	32,482	37,305
Foreign currency contracts | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative Liability	206	19,120
Derivative Asset	$ 10,380	$ 487

Derivatives - Narrative (Detail

Derivatives - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Designated as Hedging Instrument | Interest rate contracts
Derivative [Line Items]
Derivative, Notional Amount1	$ 878.2	$ 719.7
Net derivative gain (loss) included in OCI to be reclassified next 12 months	16.6
Not Designated as Hedging Instrument | Foreign currency contracts
Derivative [Line Items]
Derivative, Notional Amount1	$ 412	$ 460.8
Maximum
Derivative [Line Items]
Derivative, Term of Contract	5 years
Minimum
Derivative [Line Items]
Derivative, Term of Contract	3 months

Derivatives - Schedule of Effec

Derivatives - Schedule of Effects of Derivatives Designated as Cash Flow Hedging Instruments (Details) - Interest rate contracts - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Gain/(loss) recognized in OCI, net of tax	$ (2,712)	$ 19,983	$ 7,430	$ 41,106
Interest expense, net
Derivative Instruments, Gain (Loss) [Line Items]
Three Months Ended September 30,	$ 6,498	$ 383	$ 18,666	$ (3,819)

Derivatives - Schedule of Eff_2

Derivatives - Schedule of Effects of Derivatives Not Designated as Hedging Instruments (Details) - Foreign currency contracts - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Foreign Currency Gain (Loss) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain/(loss) recognized in income	$ 8,137	$ 33,019	$ (7,149)	$ 72,371
Interest expense, net
Derivative Instruments, Gain (Loss) [Line Items]
Gain/(loss) recognized in income	$ 204	$ 313	$ 1,357	$ (638)

Fair Value Measurements And D_3

Fair Value Measurements And Disclosures - Financial Instruments Not Required to be Carried at Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and cash equivalents, carrying amount	$ 105,172	$ 83,376	$ 57,991
Finance receivables, net, carrying amount	3,460,804	3,295,008
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Interest-bearing deposits, carrying value	100,505	112,992
Restricted Cash and Cash Equivalents	13,246		$ 1,092
Reported Value Measurement [Member]
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and cash equivalents, carrying amount	105,172	83,376
Finance receivables, net, carrying amount	3,460,804	3,295,008
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Interest-bearing deposits, carrying value	100,505	112,992
Outstanding borrowings under credit facility	1,356,481	1,060,251
Term loans, carrying amount	442,500	450,000
Senior Notes, carrying amount	1,046,000	650,000
Convertible debt	0	345,000
Estimate of Fair Value Measurement [Member]
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and cash equivalents, estimated fair value	105,172	83,376
Finance receivables, net, estimated fair value	3,005,033	3,167,813
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Interest-bearing deposits, fair value	100,505	112,992
Revolving lines of credit, estimated fair value	1,356,481	1,060,251
Term loans, estimated fair value	442,500	450,000
Debt Instrument, Fair Value Disclosure	923,125	580,433
Convertible debt, estimated fair value	$ 0	$ 341,926

Fair Value Fair Value Measureme

Fair Value Fair Value Measurements and Disclosures - Financial Instruments Required to be Carried at Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Assets, Fair Value Disclosure [Abstract]
Debt Securities, Available-for-Sale	$ 62,755	$ 66,813
Derivative Asset	42,862	37,792
Financial Liabilities Fair Value Disclosure [Abstract]
Derivative Liability	3,401	19,120
Fair Value, Inputs, Level 1 [Member]
Assets, Fair Value Disclosure [Abstract]
Derivative Asset	0	0
Financial Liabilities Fair Value Disclosure [Abstract]
Derivative Liability	0	0
Fair Value, Inputs, Level 2 [Member]
Assets, Fair Value Disclosure [Abstract]
Derivative Asset	42,862	37,792
Financial Liabilities Fair Value Disclosure [Abstract]
Derivative Liability	3,401	19,120
Fair Value, Inputs, Level 3 [Member]
Assets, Fair Value Disclosure [Abstract]
Derivative Asset	0	0
Financial Liabilities Fair Value Disclosure [Abstract]
Derivative Liability	0	0
Government Bonds [Member]
Assets, Fair Value Disclosure [Abstract]
Debt Securities, Available-for-Sale	62,755	66,813
Government Bonds [Member] | Fair Value, Inputs, Level 1 [Member]
Assets, Fair Value Disclosure [Abstract]
Debt Securities, Available-for-Sale	62,755	66,813
Government Bonds [Member] | Fair Value, Inputs, Level 2 [Member]
Assets, Fair Value Disclosure [Abstract]
Debt Securities, Available-for-Sale	0	0
Government Bonds [Member] | Fair Value, Inputs, Level 3 [Member]
Assets, Fair Value Disclosure [Abstract]
Debt Securities, Available-for-Sale	$ 0	$ 0

Fair Value - Narrative (Details

Fair Value - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment, Long-Lived Asset, Held-for-Use	$ 5,037	$ 0	$ 5,037	$ 0
Private equity funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Private equity funds	$ 2,900		$ 2,900		$ 4,400

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss - Reclassifications out of AOCI (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Interest rate swaps	$ (500)	$ (83)	$ (1,380)	$ (754)
Income tax effect of item above	1,788	11,072	(15,317)	29,828
Net income	(8,151)	27,182	(60,894)	100,936
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,189,987	1,182,589	1,189,987	1,182,589		$ 1,286,750	$ 1,242,367	$ 1,346,167	$ 1,324,837
Other comprehensive (loss)/income before reclassifications, net	(34,341)	(77,872)	(25,161)	(162,078)
Reclassifications	(4,948)	(393)	(14,202)	2,901
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(39,289)	(78,265)	(39,363)	(159,177)
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	21,032	38,636	21,032	38,636	$ 28,692	27,804	19,046		(5,371)
Other comprehensive (loss)/income before reclassifications, net	(2,712)	19,983	7,430	41,106
Reclassifications	(4,948)	(393)	(14,202)	2,901
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(7,660)	19,590	(6,772)	44,007
Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	(408,106)	(464,232)	(408,106)	(464,232)	(376,503)	(375,493)	(366,244)		(261,317)
Other comprehensive (loss)/income before reclassifications, net	(31,603)	(97,988)	(32,613)	(202,915)
Reclassifications	0	0	0	0
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(31,603)	(97,988)	(32,613)	(202,915)
Debt Securities Available-for-sale
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	(215)	(490)	(215)	(490)	(189)	(237)	(623)		(221)
Other comprehensive (loss)/income before reclassifications, net	(26)	133	22	(269)
Reclassifications	0	0	0	0
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(26)	133	22	(269)
Accumulated Other Comprehensive (Loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	(387,289)	(426,086)	(387,289)	(426,086)	$ (348,000)	$ (347,926)	$ (347,821)	$ (243,709)	$ (266,909)
Reclassification out of Accumulated Other Comprehensive Income | Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Interest rate swaps	6,498	383	18,666	(3,819)
Income tax effect of item above	(1,550)	10	(4,464)	918
Net income	$ 4,948	$ 393	$ 14,202	$ (2,901)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss - AOCI by Component (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance		$ 1,242,367	$ 1,286,750	$ 1,324,837
Other comprehensive (loss)/income before reclassifications, net	$ (34,341)	(77,872)	(25,161)	(162,078)
Reclassifications	(4,948)	(393)	(14,202)	2,901
Other comprehensive loss attributable to PRA Group, Inc.	(39,289)	(78,265)	(39,363)	(159,177)
Ending balance	1,189,987	1,182,589	1,189,987	1,182,589
Deferred taxes for unrealized losses from cash flow hedges	2,500	(3,500)	(7,000)	(6,100)
Debt Securities Available-for-sale
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(189)	(623)	(237)	(221)
Other comprehensive (loss)/income before reclassifications, net	(26)	133	22	(269)
Reclassifications	0	0	0	0
Other comprehensive loss attributable to PRA Group, Inc.	(26)	133	22	(269)
Ending balance	(215)	(490)	(215)	(490)
Cash Flow Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	28,692	19,046	27,804	(5,371)
Other comprehensive (loss)/income before reclassifications, net	(2,712)	19,983	7,430	41,106
Reclassifications	(4,948)	(393)	(14,202)	2,901
Other comprehensive loss attributable to PRA Group, Inc.	(7,660)	19,590	(6,772)	44,007
Ending balance	21,032	38,636	21,032	38,636
Currency Translation Adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(376,503)	(366,244)	(375,493)	(261,317)
Other comprehensive (loss)/income before reclassifications, net	(31,603)	(97,988)	(32,613)	(202,915)
Reclassifications	0	0	0	0
Other comprehensive loss attributable to PRA Group, Inc.	(31,603)	(97,988)	(32,613)	(202,915)
Ending balance	(408,106)	(464,232)	(408,106)	(464,232)
Accumulated Other Comprehensive (Loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(348,000)	(347,821)	(347,926)	(266,909)
Ending balance	$ (387,289)	$ (426,086)	$ (387,289)	$ (426,086)

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Schedule Of Earnings Per Share, By Common Class [Line Items]
Net income	$ (12,262)	$ 24,732	$ (74,695)	$ 101,188
Weighted Average Common Shares, Basic EPS	39,242,000	39,018,000	39,155,000	39,858,000
Weighted Average Common Shares, Dilutive effect of nonvested share awards	0	152,000	0	267,000
Weighted Average Common Shares, Diluted EPS	39,242,000	39,170,000	39,155,000	40,125,000
EPS, Basic (in dollars per share)	$ (0.31)	$ 0.63	$ (1.91)	$ 2.54
EPS, Dilutive effect of nonvested share awards (in dollars per share)	0	0	0	(0.02)
EPS, Diluted (in dollars per share)	$ (0.31)	$ 0.63	$ (1.91)	$ 2.52
Antidilutive options outstanding			0	0
February 2022 Repurchase Program
Schedule Of Earnings Per Share, By Common Class [Line Items]
Stock repurchases authorized amount	$ 150,000		$ 150,000
Stock repurchase program, remaining authorized repurchase amount	$ 67,700		$ 67,700

Income Taxes - Additional Discl

Income Taxes - Additional Disclosures (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Cash on hand related to foreign operations with permanently reinvested earnings	$ 88.8	$ 75.3

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	Sep. 30, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Future compensation under employment agreements	$ 4.3
Amount to be purchased under forward flow agreements	$ 538